0000030625 false 2025 Q1 12/31 9 1 P2Y xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure fls:segments fls:claim 0000030625 2025-01-01 2025-03-31 0000030625 2025-04-21 0000030625 2024-01-01 2024-03-31 0000030625 2025-03-31 0000030625 2024-12-31 0000030625 us-gaap:CommonStockMember 2024-12-31 0000030625 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0000030625 us-gaap:RetainedEarningsMember 2024-12-31 0000030625 us-gaap:TreasuryStockCommonMember 2024-12-31 0000030625 us-gaap:DeferredCompensationShareBasedPaymentsMember 2024-12-31 0000030625 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0000030625 us-gaap:NoncontrollingInterestMember 2024-12-31 0000030625 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0000030625 us-gaap:TreasuryStockCommonMember 2025-01-01 2025-03-31 0000030625 us-gaap:DeferredCompensationShareBasedPaymentsMember 2025-01-01 2025-03-31 0000030625 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0000030625 us-gaap:NoncontrollingInterestMember 2025-01-01 2025-03-31 0000030625 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0000030625 us-gaap:CommonStockMember 2025-03-31 0000030625 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0000030625 us-gaap:RetainedEarningsMember 2025-03-31 0000030625 us-gaap:TreasuryStockCommonMember 2025-03-31 0000030625 us-gaap:DeferredCompensationShareBasedPaymentsMember 2025-03-31 0000030625 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0000030625 us-gaap:NoncontrollingInterestMember 2025-03-31 0000030625 us-gaap:CommonStockMember 2023-12-31 0000030625 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000030625 us-gaap:RetainedEarningsMember 2023-12-31 0000030625 us-gaap:TreasuryStockCommonMember 2023-12-31 0000030625 us-gaap:DeferredCompensationShareBasedPaymentsMember 2023-12-31 0000030625 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000030625 us-gaap:NoncontrollingInterestMember 2023-12-31 0000030625 2023-12-31 0000030625 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0000030625 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-03-31 0000030625 us-gaap:DeferredCompensationShareBasedPaymentsMember 2024-01-01 2024-03-31 0000030625 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0000030625 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-03-31 0000030625 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0000030625 us-gaap:CommonStockMember 2024-03-31 0000030625 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0000030625 us-gaap:RetainedEarningsMember 2024-03-31 0000030625 us-gaap:TreasuryStockCommonMember 2024-03-31 0000030625 us-gaap:DeferredCompensationShareBasedPaymentsMember 2024-03-31 0000030625 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0000030625 us-gaap:NoncontrollingInterestMember 2024-03-31 0000030625 2024-03-31 0000030625 fls:MOGASMember 2024-10-15 2024-10-15 0000030625 fls:MOGASMember 2024-10-15 0000030625 fls:MOGASMember us-gaap:CustomerRelationshipsMember 2024-10-15 2024-10-15 0000030625 fls:MOGASMember us-gaap:OrderOrProductionBacklogMember 2024-10-15 2024-10-15 0000030625 fls:MOGASMember 2025-01-01 2025-03-31 0000030625 us-gaap:TransferredOverTimeMember 2025-01-01 2025-03-31 0000030625 us-gaap:TransferredOverTimeMember 2024-01-01 2024-03-31 0000030625 us-gaap:TransferredAtPointInTimeMember 2025-01-01 2025-03-31 0000030625 us-gaap:TransferredAtPointInTimeMember 2024-01-01 2024-03-31 0000030625 fls:OriginalEquipmentMember fls:FPDMember 2025-01-01 2025-03-31 0000030625 fls:OriginalEquipmentMember fls:FlowControlDivisionMember 2025-01-01 2025-03-31 0000030625 fls:OriginalEquipmentMember 2025-01-01 2025-03-31 0000030625 fls:AftermarketEquipmentMember fls:FPDMember 2025-01-01 2025-03-31 0000030625 fls:AftermarketEquipmentMember fls:FlowControlDivisionMember 2025-01-01 2025-03-31 0000030625 fls:AftermarketEquipmentMember 2025-01-01 2025-03-31 0000030625 fls:FPDMember 2025-01-01 2025-03-31 0000030625 fls:FlowControlDivisionMember 2025-01-01 2025-03-31 0000030625 fls:OriginalEquipmentMember fls:FPDMember 2024-01-01 2024-03-31 0000030625 fls:OriginalEquipmentMember fls:FlowControlDivisionMember 2024-01-01 2024-03-31 0000030625 fls:OriginalEquipmentMember 2024-01-01 2024-03-31 0000030625 fls:AftermarketEquipmentMember fls:FPDMember 2024-01-01 2024-03-31 0000030625 fls:AftermarketEquipmentMember fls:FlowControlDivisionMember 2024-01-01 2024-03-31 0000030625 fls:AftermarketEquipmentMember 2024-01-01 2024-03-31 0000030625 fls:FPDMember 2024-01-01 2024-03-31 0000030625 fls:FlowControlDivisionMember 2024-01-01 2024-03-31 0000030625 srt:NorthAmericaMember fls:FPDMember 2025-01-01 2025-03-31 0000030625 srt:NorthAmericaMember fls:FlowControlDivisionMember 2025-01-01 2025-03-31 0000030625 srt:NorthAmericaMember 2025-01-01 2025-03-31 0000030625 srt:LatinAmericaMember fls:FPDMember 2025-01-01 2025-03-31 0000030625 srt:LatinAmericaMember fls:FlowControlDivisionMember 2025-01-01 2025-03-31 0000030625 srt:LatinAmericaMember 2025-01-01 2025-03-31 0000030625 fls:MiddleEastAndAfricaMember fls:FPDMember 2025-01-01 2025-03-31 0000030625 fls:MiddleEastAndAfricaMember fls:FlowControlDivisionMember 2025-01-01 2025-03-31 0000030625 fls:MiddleEastAndAfricaMember 2025-01-01 2025-03-31 0000030625 srt:AsiaPacificMember fls:FPDMember 2025-01-01 2025-03-31 0000030625 srt:AsiaPacificMember fls:FlowControlDivisionMember 2025-01-01 2025-03-31 0000030625 srt:AsiaPacificMember 2025-01-01 2025-03-31 0000030625 srt:EuropeMember fls:FPDMember 2025-01-01 2025-03-31 0000030625 srt:EuropeMember fls:FlowControlDivisionMember 2025-01-01 2025-03-31 0000030625 srt:EuropeMember 2025-01-01 2025-03-31 0000030625 srt:NorthAmericaMember fls:FPDMember 2024-01-01 2024-03-31 0000030625 srt:NorthAmericaMember fls:FlowControlDivisionMember 2024-01-01 2024-03-31 0000030625 srt:NorthAmericaMember 2024-01-01 2024-03-31 0000030625 srt:LatinAmericaMember fls:FPDMember 2024-01-01 2024-03-31 0000030625 srt:LatinAmericaMember fls:FlowControlDivisionMember 2024-01-01 2024-03-31 0000030625 srt:LatinAmericaMember 2024-01-01 2024-03-31 0000030625 fls:MiddleEastAndAfricaMember fls:FPDMember 2024-01-01 2024-03-31 0000030625 fls:MiddleEastAndAfricaMember fls:FlowControlDivisionMember 2024-01-01 2024-03-31 0000030625 fls:MiddleEastAndAfricaMember 2024-01-01 2024-03-31 0000030625 srt:AsiaPacificMember fls:FPDMember 2024-01-01 2024-03-31 0000030625 srt:AsiaPacificMember fls:FlowControlDivisionMember 2024-01-01 2024-03-31 0000030625 srt:AsiaPacificMember 2024-01-01 2024-03-31 0000030625 srt:EuropeMember fls:FPDMember 2024-01-01 2024-03-31 0000030625 srt:EuropeMember fls:FlowControlDivisionMember 2024-01-01 2024-03-31 0000030625 srt:EuropeMember 2024-01-01 2024-03-31 0000030625 2025-04-01 2025-03-31 0000030625 2026-04-01 2025-03-31 0000030625 us-gaap:ShortTermContractWithCustomerMember 2024-12-31 0000030625 us-gaap:LongTermContractWithCustomerMember 2024-12-31 0000030625 fls:ShorttermContractwithCustomerLiabilityMember 2024-12-31 0000030625 fls:LongtermContractWithCustomerLiabilityMember 2024-12-31 0000030625 us-gaap:ShortTermContractWithCustomerMember 2025-01-01 2025-03-31 0000030625 us-gaap:LongTermContractWithCustomerMember 2025-01-01 2025-03-31 0000030625 fls:ShorttermContractwithCustomerLiabilityMember 2025-01-01 2025-03-31 0000030625 fls:LongtermContractWithCustomerLiabilityMember 2025-01-01 2025-03-31 0000030625 us-gaap:LongTermContractWithCustomerMember 2025-03-31 0000030625 fls:LongtermContractWithCustomerLiabilityMember 2025-03-31 0000030625 us-gaap:ShortTermContractWithCustomerMember 2023-12-31 0000030625 us-gaap:LongTermContractWithCustomerMember 2023-12-31 0000030625 fls:ShorttermContractwithCustomerLiabilityMember 2023-12-31 0000030625 fls:LongtermContractWithCustomerLiabilityMember 2023-12-31 0000030625 us-gaap:ShortTermContractWithCustomerMember 2024-01-01 2024-03-31 0000030625 us-gaap:LongTermContractWithCustomerMember 2024-01-01 2024-03-31 0000030625 fls:ShorttermContractwithCustomerLiabilityMember 2024-01-01 2024-03-31 0000030625 fls:LongtermContractWithCustomerLiabilityMember 2024-01-01 2024-03-31 0000030625 us-gaap:LongTermContractWithCustomerMember 2024-03-31 0000030625 fls:LongtermContractWithCustomerLiabilityMember 2024-03-31 0000030625 fls:Plan2020Member 2020-01-01 0000030625 us-gaap:RestrictedStockMember 2025-01-01 2025-03-31 0000030625 us-gaap:RestrictedStockMember 2025-03-31 0000030625 us-gaap:RestrictedStockMember 2024-12-31 0000030625 us-gaap:RestrictedStockMember srt:MaximumMember 2025-01-01 2025-03-31 0000030625 us-gaap:RestrictedStockMember srt:MinimumMember 2025-01-01 2025-03-31 0000030625 us-gaap:RestrictedStockMember 2024-01-01 2024-03-31 0000030625 us-gaap:PerformanceSharesMember 2025-03-31 0000030625 us-gaap:PerformanceSharesMember srt:MaximumMember fls:IssueDate2022And2021Member 2025-01-01 2025-03-31 0000030625 us-gaap:PerformanceSharesMember 2025-01-01 2025-03-31 0000030625 us-gaap:PerformanceSharesMember srt:MinimumMember 2025-03-31 0000030625 us-gaap:PerformanceSharesMember srt:MaximumMember 2025-03-31 0000030625 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2025-03-31 0000030625 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2024-12-31 0000030625 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2025-01-01 2025-03-31 0000030625 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2025-03-31 0000030625 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2024-12-31 0000030625 us-gaap:ForwardContractsMember 2025-01-01 2025-03-31 0000030625 us-gaap:ForwardContractsMember 2024-01-01 2024-03-31 0000030625 fls:A2030USDSeniorNotesMember 2025-03-31 0000030625 fls:A2030USDSeniorNotesMember 2024-12-31 0000030625 fls:USDSeniorNotesDue2032Member 2025-03-31 0000030625 fls:USDSeniorNotesDue2032Member 2024-12-31 0000030625 fls:TermLoanFacilityMember 2025-03-31 0000030625 fls:TermLoanFacilityMember 2024-12-31 0000030625 fls:SeniorCreditFacilityMember us-gaap:RevolvingCreditFacilityMember 2021-09-13 0000030625 fls:SeniorCreditFacilityMember us-gaap:LetterOfCreditMember 2021-09-13 0000030625 fls:SeniorCreditFacilityMember us-gaap:BridgeLoanMember 2021-09-13 0000030625 fls:TermLoanFacilityMember 2021-09-13 0000030625 fls:SeniorCreditFacilityMember 2021-09-13 0000030625 fls:SeniorCreditFacilityMember 2023-02-03 0000030625 fls:NewSeniorCreditFacilityMember us-gaap:RevolvingCreditFacilityMember 2021-09-13 0000030625 fls:NewSeniorCreditFacilityMember us-gaap:RevolvingCreditFacilityMember 2024-10-10 0000030625 fls:TermLoanFacilityMember 2024-10-10 0000030625 fls:SeniorCreditFacilityMember us-gaap:RevolvingCreditFacilityMember us-gaap:SecuredOvernightFinancingRateSofrMember srt:MinimumMember 2021-09-13 2021-09-13 0000030625 fls:SeniorCreditFacilityMember us-gaap:RevolvingCreditFacilityMember us-gaap:SecuredOvernightFinancingRateSofrMember srt:MaximumMember 2021-09-13 2021-09-13 0000030625 fls:SeniorCreditFacilityMember us-gaap:RevolvingCreditFacilityMember us-gaap:BaseRateMember srt:MinimumMember 2021-09-13 2021-09-13 0000030625 fls:SeniorCreditFacilityMember us-gaap:RevolvingCreditFacilityMember us-gaap:BaseRateMember srt:MaximumMember 2021-09-13 2021-09-13 0000030625 fls:SeniorCreditFacilityMember us-gaap:RevolvingCreditFacilityMember us-gaap:SecuredOvernightFinancingRateSofrMember 2025-01-01 2025-03-31 0000030625 fls:SeniorCreditFacilityMember us-gaap:RevolvingCreditFacilityMember us-gaap:BaseRateMember 2025-01-01 2025-03-31 0000030625 fls:SeniorCreditFacilityMember us-gaap:RevolvingCreditFacilityMember srt:MinimumMember 2021-09-13 2021-09-13 0000030625 fls:SeniorCreditFacilityMember us-gaap:RevolvingCreditFacilityMember srt:MaximumMember 2021-09-13 2021-09-13 0000030625 fls:SeniorCreditFacilityMember us-gaap:RevolvingCreditFacilityMember 2025-01-01 2025-03-31 0000030625 fls:NewSeniorCreditFacilityMember us-gaap:RevolvingCreditFacilityMember fls:AdjustedTermSOFRMember 2021-09-13 2021-09-13 0000030625 fls:TermLoanFacilityMember us-gaap:BaseRateMember 2025-01-01 2025-03-31 0000030625 fls:SeniorCreditFacilityMember us-gaap:LetterOfCreditMember 2025-03-31 0000030625 fls:SeniorCreditFacilityMember us-gaap:LetterOfCreditMember 2024-12-31 0000030625 fls:SeniorCreditFacilityMember us-gaap:RevolvingCreditFacilityMember 2025-03-31 0000030625 fls:SeniorCreditFacilityMember us-gaap:RevolvingCreditFacilityMember 2024-12-31 0000030625 fls:TermLoanFacilityMember srt:ScenarioForecastMember 2025-10-01 2025-12-31 0000030625 fls:TermLoanFacilityMember srt:ScenarioForecastMember 2025-04-01 2025-06-30 0000030625 fls:TermLoanFacilityMember srt:ScenarioForecastMember 2026-01-01 2026-03-31 0000030625 fls:TermLoanFacilityMember srt:ScenarioForecastMember 2025-07-01 2025-09-30 0000030625 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2025-03-31 0000030625 us-gaap:DomesticPlanMember 2025-01-01 2025-03-31 0000030625 us-gaap:DomesticPlanMember 2024-01-01 2024-03-31 0000030625 us-gaap:ForeignPlanMember 2025-01-01 2025-03-31 0000030625 us-gaap:ForeignPlanMember 2024-01-01 2024-03-31 0000030625 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2025-01-01 2025-03-31 0000030625 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2024-01-01 2024-03-31 0000030625 srt:MinimumMember srt:ScenarioForecastMember 2025-01-01 2025-12-31 0000030625 srt:MaximumMember srt:ScenarioForecastMember 2025-01-01 2025-12-31 0000030625 us-gaap:DomesticPlanMember 2025-01-31 0000030625 fls:Sharerepurchaseprogram2014Member 2017-12-31 0000030625 2024-02-19 0000030625 us-gaap:OperatingSegmentsMember fls:FPDMember 2025-01-01 2025-03-31 0000030625 us-gaap:OperatingSegmentsMember fls:FCDMember 2025-01-01 2025-03-31 0000030625 us-gaap:OperatingSegmentsMember 2025-01-01 2025-03-31 0000030625 us-gaap:IntersegmentEliminationMember 2025-01-01 2025-03-31 0000030625 us-gaap:OperatingSegmentsMember fls:FPDMember 2025-03-31 0000030625 us-gaap:OperatingSegmentsMember fls:FCDMember 2025-03-31 0000030625 us-gaap:OperatingSegmentsMember 2025-03-31 0000030625 us-gaap:IntersegmentEliminationMember 2025-03-31 0000030625 us-gaap:OperatingSegmentsMember fls:FPDMember 2024-01-01 2024-03-31 0000030625 us-gaap:OperatingSegmentsMember fls:FCDMember 2024-01-01 2024-03-31 0000030625 us-gaap:OperatingSegmentsMember 2024-01-01 2024-03-31 0000030625 us-gaap:IntersegmentEliminationMember 2024-01-01 2024-03-31 0000030625 us-gaap:OperatingSegmentsMember fls:FPDMember 2024-03-31 0000030625 us-gaap:OperatingSegmentsMember fls:FCDMember 2024-03-31 0000030625 us-gaap:OperatingSegmentsMember 2024-03-31 0000030625 us-gaap:IntersegmentEliminationMember 2024-03-31 0000030625 us-gaap:MaterialReconcilingItemsMember 2025-01-01 2025-03-31 0000030625 us-gaap:MaterialReconcilingItemsMember 2024-01-01 2024-03-31 0000030625 us-gaap:AccumulatedTranslationAdjustmentMember 2024-12-31 0000030625 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-12-31 0000030625 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-12-31 0000030625 us-gaap:AccumulatedTranslationAdjustmentMember 2023-12-31 0000030625 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-12-31 0000030625 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-12-31 0000030625 us-gaap:AccumulatedTranslationAdjustmentMember 2025-01-01 2025-03-31 0000030625 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2025-01-01 2025-03-31 0000030625 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2025-01-01 2025-03-31 0000030625 us-gaap:AccumulatedTranslationAdjustmentMember 2024-01-01 2024-03-31 0000030625 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-01-01 2024-03-31 0000030625 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-01-01 2024-03-31 0000030625 us-gaap:AccumulatedTranslationAdjustmentMember 2025-03-31 0000030625 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2025-03-31 0000030625 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2025-03-31 0000030625 us-gaap:AccumulatedTranslationAdjustmentMember 2024-03-31 0000030625 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-03-31 0000030625 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-03-31 0000030625 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2025-01-01 2025-03-31 0000030625 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2024-01-01 2024-03-31 0000030625 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2025-01-01 2025-03-31 0000030625 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2024-01-01 2024-03-31 0000030625 fls:AccumulatedDefinedBenefitPlansAdjustmentNetSettlementGainLossAttributableToParentMember 2025-01-01 2025-03-31 0000030625 fls:AccumulatedDefinedBenefitPlansAdjustmentNetSettlementGainLossAttributableToParentMember 2024-01-01 2024-03-31 0000030625 fls:A2023RealignmentProgramMember 2023-04-01 2023-05-01 0000030625 us-gaap:CostOfSalesMember fls:FPDMember 2025-01-01 2025-03-31 0000030625 us-gaap:CostOfSalesMember fls:FlowControlDivisionMember 2025-01-01 2025-03-31 0000030625 us-gaap:CostOfSalesMember us-gaap:OperatingSegmentsMember 2025-01-01 2025-03-31 0000030625 us-gaap:CostOfSalesMember us-gaap:IntersegmentEliminationMember 2025-01-01 2025-03-31 0000030625 us-gaap:CostOfSalesMember 2025-01-01 2025-03-31 0000030625 us-gaap:SellingGeneralAndAdministrativeExpensesMember fls:FPDMember 2025-01-01 2025-03-31 0000030625 us-gaap:SellingGeneralAndAdministrativeExpensesMember fls:FlowControlDivisionMember 2025-01-01 2025-03-31 0000030625 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:OperatingSegmentsMember 2025-01-01 2025-03-31 0000030625 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:IntersegmentEliminationMember 2025-01-01 2025-03-31 0000030625 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2025-01-01 2025-03-31 0000030625 us-gaap:CostOfSalesMember fls:FPDMember 2024-01-01 2024-03-31 0000030625 us-gaap:CostOfSalesMember fls:FlowControlDivisionMember 2024-01-01 2024-03-31 0000030625 us-gaap:CostOfSalesMember us-gaap:OperatingSegmentsMember 2024-01-01 2024-03-31 0000030625 us-gaap:CostOfSalesMember us-gaap:IntersegmentEliminationMember 2024-01-01 2024-03-31 0000030625 us-gaap:CostOfSalesMember 2024-01-01 2024-03-31 0000030625 us-gaap:SellingGeneralAndAdministrativeExpensesMember fls:FPDMember 2024-01-01 2024-03-31 0000030625 us-gaap:SellingGeneralAndAdministrativeExpensesMember fls:FlowControlDivisionMember 2024-01-01 2024-03-31 0000030625 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:OperatingSegmentsMember 2024-01-01 2024-03-31 0000030625 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:IntersegmentEliminationMember 2024-01-01 2024-03-31 0000030625 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2024-01-01 2024-03-31 0000030625 fls:RealignmentPrograms2025Member us-gaap:CostOfSalesMember fls:FPDMember 2020-04-01 2022-03-31 0000030625 fls:RealignmentPrograms2025Member us-gaap:CostOfSalesMember fls:FlowControlDivisionMember 2020-04-01 2022-03-31 0000030625 fls:RealignmentPrograms2025Member us-gaap:CostOfSalesMember us-gaap:OperatingSegmentsMember 2020-04-01 2022-03-31 0000030625 fls:RealignmentPrograms2025Member us-gaap:CostOfSalesMember us-gaap:IntersegmentEliminationMember 2020-04-01 2022-03-31 0000030625 us-gaap:CostOfSalesMember fls:RealignmentPrograms2025Member 2020-04-01 2022-03-31 0000030625 fls:RealignmentPrograms2025Member us-gaap:SellingGeneralAndAdministrativeExpensesMember fls:FPDMember 2020-04-01 2022-03-31 0000030625 fls:RealignmentPrograms2025Member us-gaap:SellingGeneralAndAdministrativeExpensesMember fls:FlowControlDivisionMember 2020-04-01 2022-03-31 0000030625 fls:RealignmentPrograms2025Member us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:OperatingSegmentsMember 2020-04-01 2022-03-31 0000030625 fls:RealignmentPrograms2025Member us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:IntersegmentEliminationMember 2020-04-01 2022-03-31 0000030625 us-gaap:SellingGeneralAndAdministrativeExpensesMember fls:RealignmentPrograms2025Member 2020-04-01 2022-03-31 0000030625 fls:RealignmentPrograms2025Member fls:FPDMember 2020-04-01 2022-03-31 0000030625 fls:RealignmentPrograms2025Member fls:FlowControlDivisionMember 2020-04-01 2022-03-31 0000030625 us-gaap:OperatingSegmentsMember fls:RealignmentPrograms2025Member 2020-04-01 2022-03-31 0000030625 us-gaap:IntersegmentEliminationMember fls:RealignmentPrograms2025Member 2020-04-01 2022-03-31 0000030625 fls:RealignmentPrograms2025Member 2020-04-01 2022-03-31 0000030625 fls:A2023RealignmentProgramMember us-gaap:CostOfSalesMember us-gaap:OperatingSegmentsMember fls:FPDMember 2018-04-01 2025-03-31 0000030625 fls:A2023RealignmentProgramMember us-gaap:CostOfSalesMember us-gaap:OperatingSegmentsMember fls:FCDMember 2018-04-01 2025-03-31 0000030625 fls:A2023RealignmentProgramMember us-gaap:CostOfSalesMember us-gaap:OperatingSegmentsMember 2018-04-01 2025-03-31 0000030625 fls:A2023RealignmentProgramMember us-gaap:CostOfSalesMember us-gaap:IntersegmentEliminationMember 2018-04-01 2025-03-31 0000030625 us-gaap:CostOfSalesMember fls:A2023RealignmentProgramMember 2018-04-01 2025-03-31 0000030625 fls:A2023RealignmentProgramMember us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:OperatingSegmentsMember fls:FPDMember 2018-04-01 2025-03-31 0000030625 fls:A2023RealignmentProgramMember us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:OperatingSegmentsMember fls:FCDMember 2018-04-01 2025-03-31 0000030625 fls:A2023RealignmentProgramMember us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:OperatingSegmentsMember 2018-04-01 2025-03-31 0000030625 fls:A2023RealignmentProgramMember us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:IntersegmentEliminationMember 2018-04-01 2025-03-31 0000030625 us-gaap:SellingGeneralAndAdministrativeExpensesMember fls:A2023RealignmentProgramMember 2018-04-01 2025-03-31 0000030625 fls:A2023RealignmentProgramMember fls:IncomeTaxExpenseMember us-gaap:OperatingSegmentsMember fls:FPDMember 2018-04-01 2025-03-31 0000030625 fls:A2023RealignmentProgramMember fls:IncomeTaxExpenseMember us-gaap:OperatingSegmentsMember fls:FCDMember 2018-04-01 2025-03-31 0000030625 fls:A2023RealignmentProgramMember fls:IncomeTaxExpenseMember us-gaap:OperatingSegmentsMember 2018-04-01 2025-03-31 0000030625 fls:A2023RealignmentProgramMember fls:IncomeTaxExpenseMember us-gaap:IntersegmentEliminationMember 2018-04-01 2025-03-31 0000030625 fls:IncomeTaxExpenseMember fls:A2023RealignmentProgramMember 2018-04-01 2025-03-31 0000030625 fls:A2023RealignmentProgramMember us-gaap:OperatingSegmentsMember fls:FPDMember 2018-04-01 2025-03-31 0000030625 fls:A2023RealignmentProgramMember us-gaap:OperatingSegmentsMember fls:FCDMember 2018-04-01 2025-03-31 0000030625 us-gaap:OperatingSegmentsMember fls:A2023RealignmentProgramMember 2018-04-01 2025-03-31 0000030625 us-gaap:IntersegmentEliminationMember fls:A2023RealignmentProgramMember 2018-04-01 2025-03-31 0000030625 fls:A2023RealignmentProgramMember 2018-04-01 2025-03-31 0000030625 us-gaap:CostOfSalesMember us-gaap:EmployeeSeveranceMember 2025-01-01 2025-03-31 0000030625 us-gaap:CostOfSalesMember us-gaap:ContractTerminationMember 2025-01-01 2025-03-31 0000030625 us-gaap:CostOfSalesMember fls:AssetWriteDownsMember 2025-01-01 2025-03-31 0000030625 us-gaap:CostOfSalesMember us-gaap:OtherExpenseMember 2025-01-01 2025-03-31 0000030625 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:EmployeeSeveranceMember 2025-01-01 2025-03-31 0000030625 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:ContractTerminationMember 2025-01-01 2025-03-31 0000030625 us-gaap:SellingGeneralAndAdministrativeExpensesMember fls:AssetWriteDownsMember 2025-01-01 2025-03-31 0000030625 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:OtherExpenseMember 2025-01-01 2025-03-31 0000030625 us-gaap:EmployeeSeveranceMember 2025-01-01 2025-03-31 0000030625 us-gaap:ContractTerminationMember 2025-01-01 2025-03-31 0000030625 fls:AssetWriteDownsMember 2025-01-01 2025-03-31 0000030625 us-gaap:OtherExpenseMember 2025-01-01 2025-03-31 0000030625 us-gaap:CostOfSalesMember us-gaap:EmployeeSeveranceMember 2024-01-01 2024-03-31 0000030625 us-gaap:CostOfSalesMember us-gaap:ContractTerminationMember 2024-01-01 2024-03-31 0000030625 us-gaap:CostOfSalesMember fls:AssetWriteDownsMember 2024-01-01 2024-03-31 0000030625 us-gaap:CostOfSalesMember us-gaap:OtherExpenseMember 2024-01-01 2024-03-31 0000030625 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:EmployeeSeveranceMember 2024-01-01 2024-03-31 0000030625 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:ContractTerminationMember 2024-01-01 2024-03-31 0000030625 us-gaap:SellingGeneralAndAdministrativeExpensesMember fls:AssetWriteDownsMember 2024-01-01 2024-03-31 0000030625 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:OtherExpenseMember 2024-01-01 2024-03-31 0000030625 us-gaap:EmployeeSeveranceMember 2024-01-01 2024-03-31 0000030625 us-gaap:ContractTerminationMember 2024-01-01 2024-03-31 0000030625 fls:AssetWriteDownsMember 2024-01-01 2024-03-31 0000030625 us-gaap:OtherExpenseMember 2024-01-01 2024-03-31 0000030625 us-gaap:EmployeeSeveranceMember fls:RealignmentPrograms2025Member us-gaap:CostOfSalesMember 2020-04-01 2022-03-31 0000030625 us-gaap:ContractTerminationMember fls:RealignmentPrograms2025Member us-gaap:CostOfSalesMember 2020-04-01 2022-03-31 0000030625 fls:AssetWriteDownsMember fls:RealignmentPrograms2025Member us-gaap:CostOfSalesMember 2020-04-01 2022-03-31 0000030625 us-gaap:OtherExpenseMember fls:RealignmentPrograms2025Member us-gaap:CostOfSalesMember 2020-04-01 2022-03-31 0000030625 us-gaap:EmployeeSeveranceMember fls:RealignmentPrograms2025Member us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-04-01 2022-03-31 0000030625 us-gaap:ContractTerminationMember fls:RealignmentPrograms2025Member us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-04-01 2022-03-31 0000030625 fls:AssetWriteDownsMember fls:RealignmentPrograms2025Member us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-04-01 2022-03-31 0000030625 us-gaap:OtherExpenseMember fls:RealignmentPrograms2025Member us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-04-01 2022-03-31 0000030625 us-gaap:EmployeeSeveranceMember fls:RealignmentPrograms2025Member 2020-04-01 2022-03-31 0000030625 us-gaap:ContractTerminationMember fls:RealignmentPrograms2025Member 2020-04-01 2022-03-31 0000030625 fls:AssetWriteDownsMember fls:RealignmentPrograms2025Member 2020-04-01 2022-03-31 0000030625 us-gaap:OtherExpenseMember fls:RealignmentPrograms2025Member 2020-04-01 2022-03-31 0000030625 us-gaap:EmployeeSeveranceMember fls:A2023RealignmentProgramMember us-gaap:CostOfSalesMember 2018-04-01 2025-03-31 0000030625 us-gaap:ContractTerminationMember fls:A2023RealignmentProgramMember us-gaap:CostOfSalesMember 2018-04-01 2025-03-31 0000030625 fls:AssetWriteDownsMember fls:A2023RealignmentProgramMember us-gaap:CostOfSalesMember 2018-04-01 2025-03-31 0000030625 us-gaap:OtherExpenseMember fls:A2023RealignmentProgramMember us-gaap:CostOfSalesMember 2018-04-01 2025-03-31 0000030625 us-gaap:EmployeeSeveranceMember fls:A2023RealignmentProgramMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-04-01 2025-03-31 0000030625 us-gaap:ContractTerminationMember fls:A2023RealignmentProgramMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-04-01 2025-03-31 0000030625 fls:AssetWriteDownsMember fls:A2023RealignmentProgramMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-04-01 2025-03-31 0000030625 us-gaap:OtherExpenseMember fls:A2023RealignmentProgramMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-04-01 2025-03-31 0000030625 us-gaap:EmployeeSeveranceMember fls:A2023RealignmentProgramMember fls:IncomeTaxExpenseMember 2018-04-01 2025-03-31 0000030625 us-gaap:ContractTerminationMember fls:A2023RealignmentProgramMember fls:IncomeTaxExpenseMember 2018-04-01 2025-03-31 0000030625 fls:AssetWriteDownsMember fls:A2023RealignmentProgramMember fls:IncomeTaxExpenseMember 2018-04-01 2025-03-31 0000030625 us-gaap:OtherExpenseMember fls:A2023RealignmentProgramMember fls:IncomeTaxExpenseMember 2018-04-01 2025-03-31 0000030625 us-gaap:EmployeeSeveranceMember fls:A2023RealignmentProgramMember 2018-04-01 2025-03-31 0000030625 us-gaap:ContractTerminationMember fls:A2023RealignmentProgramMember 2018-04-01 2025-03-31 0000030625 fls:AssetWriteDownsMember fls:A2023RealignmentProgramMember 2018-04-01 2025-03-31 0000030625 us-gaap:OtherExpenseMember fls:A2023RealignmentProgramMember 2018-04-01 2025-03-31 0000030625 fls:ChargesExpectedtobeSettledinCashMember 2025-01-01 2025-03-31 0000030625 fls:ChargesExpectedtobeSettledinCashMember 2024-01-01 2024-03-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025
OR
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission File No. 1-13179
FLOWSERVE CORPORATION
(Exact name of registrant as specified in its charter)

New York |  | 31-0267900
(State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification No.)
5215 N. O’Connor Boulevard, Suite 700, | Irving, | Texas |  | 75039
(Address of principal executive offices) |  | (Zip Code)

|  |  | (972) | 443-6500 |
(Registrant’s telephone number, including area code)
Former name, former address and former fiscal year, if changed since last report: N/A
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class | Trading Symbol | Name of Each Exchange on Which Registered
Common Stock, $1.25 Par Value | FLS | New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☑ Yes ¨ No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☑ Yes ¨ No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer | ☑ | Accelerated filer | ☐ | Non-accelerated filer | ☐
Smaller reporting company | ☐ | Emerging growth company | ☐ |  |

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑
As of April 21, 2025 there were 130,728,620 shares of the issuer’s common stock outstanding.

FLOWSERVE CORPORATION
FORM 10-Q
TABLE OF CONTENTS

| Page
| No.
PART I – FINANCIAL INFORMATION |
Item 1. Financial Statements |
Condensed Consolidated Statements of Income and Condensed Consolidated Statements of Comprehensive Income – Three Months Ended March 31, 202 5 and 202 4 (unaudited) | 1
Condensed Consolidated Balance Sheets – March 31, 202 5 and December 31, 202 4 (unaudited) | 2
Condensed Consolidated Statements of Shareholders' Equity – Three Months Ended March 31, 202 5 and 202 4 (unaudited) | 3
Condensed Consolidated Statements of Cash Flows – Three Months Ended March 31, 202 5 and 202 4 (unaudited) | 4
Notes to Condensed Consolidated Financial Statements (unaudited) | 5
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations | 25
Item 3. Quantitative and Qualitative Disclosures About Market Risk | 35
Item 4. Controls and Procedures | 35
PART II – OTHER INFORMATION |
Item 1. Legal Proceedings | 36
Item 1A. Risk Factors | 36
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds | 36
Item 3. Defaults Upon Senior Securities | 38
Item 4. Mine Safety Disclosures | 38
Item 5. Other Information | 38
Item 6. Exhibits | 38
SIGNATURES | 39

i

PART I — FINANCIAL INFORMATION
Item 1.Financial Statements
FLOWSERVE CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)

(Amounts in thousands, except per share data) | Three Months Ended March 31,
| 2025 |  | 2024
Sales | $ | 1,144,543 |  |  | $ | 1,087,479 |
Cost of sales | (775,209) |  |  | (748,511) |
Gross profit | 369,334 |  |  | 338,968 |
Selling, general and administrative expense | (243,177) |  |  | (228,418) |
Net earnings from affiliates | 5,732 |  |  | 2,529 |
Operating income | 131,889 |  |  | 113,079 |
Interest expense | (19,175) |  |  | (15,317) |
Interest income | 1,745 |  |  | 1,169 |
Other income (expense), net | (17,259) |  |  | (874) |
Earnings (loss) before income taxes | 97,200 |  |  | 98,057 |
(Provision for) benefit from income taxes | (17,743) |  |  | (20,142) |
Net earnings (loss), including noncontrolling interests | 79,457 |  |  | 77,915 |
Less: Net earnings attributable to noncontrolling interests | (5,552) |  |  | (3,695) |
Net earnings (loss) attributable to Flowserve Corporation | $ | 73,905 |  |  | $ | 74,220 |
Net earnings (loss) per share attributable to Flowserve Corporation common shareholders: |  |  |
Basic | $ | 0.56 |  |  | $ | 0.56 |
Diluted | 0.56 |  |  | 0.56 |
Weighted average shares – basic | 131,566 |  |  | 131,510 |
Weighted average shares – diluted | 132,670 |  |  | 132,368 |

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Unaudited)

(Amounts in thousands) | Three Months Ended March 31,
| 2025 |  | 2024
Net earnings, including noncontrolling interests | $ | 79,457 |  |  | $ | 77,915 |
Other comprehensive income (loss): |  |  |
Foreign currency translation adjustments, net of taxes of $(1,907) and $828, respectively | 47,571 |  |  | (28,244) |
Pension and other postretirement effects, net of taxes of $(387) and $76, respectively | 334 |  |  | 1,376 |
Cash flow hedging activity, net of taxes of $(7) and $(35), respectively | 24 |  |  | (5) |
Other comprehensive income (loss) | 47,929 |  |  | (26,873) |
Comprehensive income, including noncontrolling interests | 127,386 |  |  | 51,042 |
Comprehensive (income) loss attributable to noncontrolling interests | (5,585) |  |  | (3,482) |
Comprehensive income attributable to Flowserve Corporation | $ | 121,801 |  |  | $ | 47,560 |

See accompanying notes to condensed consolidated financial statements.
1

FLOWSERVE CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)

(Amounts in thousands, except par value) | March 31, |  | December 31,
| 2025 |  | 2024
ASSETS
Current assets: |  |  |
Cash and cash equivalents | $ | 540,804 |  |  | $ | 675,441 |
Accounts receivable, net of allowance for expected credit losses of $85,444 and $79,059, respectively | 1,043,707 |  |  | 976,739 |
Contract assets, net of allowance for expected credit losses of $3,997 and $3,404, respectively | 312,154 |  |  | 298,906 |
Inventories | 841,546 |  |  | 837,254 |
Prepaid expenses and other | 126,696 |  |  | 116,157 |
Total current assets | 2,864,907 |  |  | 2,904,497 |
Property, plant and equipment, net of accumulated depreciation of $1,173,858 and $1,142,667, respectively | 542,490 |  |  | 539,703 |
Operating lease right-of-use assets, net | 161,743 |  |  | 159,400 |
Goodwill | 1,303,111 |  |  | 1,286,295 |
Deferred taxes | 219,849 |  |  | 221,742 |
Other intangible assets, net | 184,689 |  |  | 188,604 |
Other assets, net of allowance for expected credit losses of $65,940 and $66,081, respectively | 206,509 |  |  | 200,580 |
Total assets | $ | 5,483,298 |  |  | $ | 5,500,821 |
LIABILITIES AND EQUITY
Current liabilities: |  |  |
Accounts payable | $ | 537,827 |  |  | $ | 545,310 |
Accrued liabilities | 481,888 |  |  | 561,486 |
Contract liabilities | 284,697 |  |  | 283,670 |
Debt due within one year | 44,197 |  |  | 44,059 |
Operating lease liabilities | 33,689 |  |  | 33,559 |
Total current liabilities | 1,382,298 |  |  | 1,468,084 |
Long-term debt due after one year | 1,451,214 |  |  | 1,460,132 |
Operating lease liabilities | 150,825 |  |  | 149,838 |
Retirement obligations and other liabilities | 369,696 |  |  | 371,055 |
Contingencies (See Note 12) |  |  |
Shareholders’ equity: |  |  |
Preferred shares, $1.00 par value | — |  |  | — |
Shares authorized – 1,000, no shares issued |  |  |
Common shares, $1.25 par value | 220,991 |  |  | 220,991 |
Shares authorized – 305,000 |  |  |
Shares issued – 176,793 and 176,793, respectively |  |  |
Capital in excess of par value | 482,529 |  |  | 502,045 |
Retained earnings | 4,071,710 |  |  | 4,025,750 |
Treasury shares, at cost – 45,616 and 45,688 shares, respectively | (2,010,045) |  |  | (2,007,869) |
Deferred compensation obligation | 8,114 |  |  | 8,172 |
Accumulated other comprehensive loss | (693,528) |  |  | (741,424) |
Total Flowserve Corporation shareholders’ equity | 2,079,771 |  |  | 2,007,665 |
Noncontrolling interests | 49,494 |  |  | 44,047 |
Total equity | 2,129,265 |  |  | 2,051,712 |
Total liabilities and equity | $ | 5,483,298 |  |  | $ | 5,500,821 |

See accompanying notes to condensed consolidated financial statements.
2

FLOWSERVE CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY
(Unaudited)

| Total Flowserve Corporation Shareholders’ Equity |  |  |  |
|  |  |  |  | Capital in Excess of Par Value |  | Retained Earnings |  |  |  |  |  | Deferred Compensation Obligation |  | Accumulated Other Comprehensive Income (Loss) |  |  |  | Total Equity
| Common Stock |  |  |  | Treasury Stock |  |  |  | Non- controlling Interests |
| Shares |  | Amount |  |  |  | Shares |  | Amount |  |  |  |
| (Amounts in thousands)
Balance — January 1, 2025 | 176,793 |  |  | $ | 220,991 |  |  | $ | 502,045 |  |  | $ | 4,025,750 |  |  | (45,688) |  |  | $ | (2,007,869) |  |  | $ | 8,172 |  |  | $ | (741,424) |  |  | $ | 44,047 |  |  | $ | 2,051,712 |
Stock activity under stock plans | — |  |  | — |  |  | (28,172) |  |  | — |  |  | 499 |  |  | 18,912 |  |  | (58) |  |  | — |  |  | — |  |  | (9,318) |
Stock-based compensation | — |  |  |  |  | 8,656 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 8,656 |
Net earnings | — |  |  | — |  |  | — |  |  | 73,905 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 5,552 |  |  | 79,457 |
Cash dividends declared ($0.21 per share) | — |  |  | — |  |  | — |  |  | (27,945) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (27,945) |
Repurchases of common shares | — |  |  | — |  |  | — |  |  | — |  |  | (427) |  |  | (21,088) |  |  | — |  |  | — |  |  | — |  |  | (21,088) |
Other comprehensive income (loss), net of tax | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 47,896 |  |  | 33 |  |  | 47,929 |
Other, net | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (138) |  |  | (138) |
Balance — March 31, 2025 | 176,793 |  |  | $ | 220,991 |  |  | $ | 482,529 |  |  | $ | 4,071,710 |  |  | (45,616) |  |  | $ | (2,010,045) |  |  | $ | 8,114 |  |  | $ | (693,528) |  |  | $ | 49,494 |  |  | $ | 2,129,265 |
Balance — January 1, 2024 | 176,793 |  |  | $ | 220,991 |  |  | $ | 506,525 |  |  | $ | 3,854,717 |  |  | (45,885) |  |  | $ | (2,014,474) |  |  | $ | 7,942 |  |  | $ | (639,601) |  |  | $ | 38,951 |  |  | $ | 1,975,051 |
Stock activity under stock plans | — |  |  | — |  |  | (31,219) |  |  | — |  |  | 570 |  |  | 24,619 |  |  | (1,175) |  |  | — |  |  | — |  |  | (7,775) |
Stock-based compensation | — |  |  |  |  | 8,657 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 8,657 |
Net earnings | — |  |  | — |  |  | — |  |  | 74,220 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 3,695 |  |  | 77,915 |
Cash dividends declared ($0.21 per share) | — |  |  | — |  |  | — |  |  | (28,015) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (28,015) |
Repurchases of common shares | — |  |  | — |  |  | — |  |  | — |  |  | (57) |  |  | (2,549) |  |  | — |  |  | — |  |  | — |  |  | (2,549) |
Other comprehensive income (loss), net of tax | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (26,659) |  |  | (214) |  |  | (26,873) |
Other, net | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 1 |  |  | (200) |  |  | (199) |
Balance — March 31, 2024 | 176,793 |  |  | $ | 220,991 |  |  | $ | 483,963 |  |  | $ | 3,900,922 |  |  | (45,372) |  |  | $ | (1,992,404) |  |  | $ | 6,767 |  |  | $ | (666,259) |  |  | $ | 42,232 |  |  | $ | 1,996,212 |
See accompanying notes to condensed consolidated financial statements.

3

FLOWSERVE CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)

(Amounts in thousands) | Three Months Ended March 31,
| 2025 |  | 2024
Cash flows – Operating activities: |  |  |
Net earnings, including noncontrolling interests | $ | 79,457 |  |  | $ | 77,915 |
Adjustments to reconcile net earnings to net cash provided (used) by operating activities: |  |  |
Depreciation | 18,831 |  |  | 19,326 |
Amortization of intangible and other assets | 5,571 |  |  | 2,254 |
Stock-based compensation | 8,656 |  |  | 8,657 |
Foreign currency, asset write downs and other non-cash adjustments | (7,350) |  |  | 1,189 |
Change in assets and liabilities: |  |  |
Accounts receivable, net | (50,679) |  |  | (39,687) |
Inventories | 8,804 |  |  | (11,452) |
Contract assets, net | (9,447) |  |  | (8,051) |
Prepaid expenses and other assets, net | 6,669 |  |  | (16,001) |
Accounts payable | (16,861) |  |  | 5,053 |
Contract liabilities | (3,648) |  |  | (6,372) |
Accrued liabilities | (89,467) |  |  | 30,917 |
Retirement obligations and other liabilities | (5,448) |  |  | (2,426) |
Net deferred taxes | 4,978 |  |  | 935 |
Net cash flows provided (used) by operating activities | (49,934) |  |  | 62,257 |
Cash flows – Investing activities: |  |  |
Capital expenditures | (11,738) |  |  | (13,610) |
Proceeds from disposal of assets | 462 |  |  | 24 |
Net cash flows (used) by investing activities | (11,276) |  |  | (13,586) |
Cash flows – Financing activities: |  |  |
Payments on term loan | (9,375) |  |  | (15,000) |
Proceeds under other financing arrangements | 150 |  |  | 72 |
Payments under other financing arrangements | (101) |  |  | (25) |
Repurchases of common shares | (21,088) |  |  | (2,549) |
Payments related to tax withholding for stock-based compensation | (11,063) |  |  | (8,857) |
Payments of dividends | (27,617) |  |  | (27,654) |
Contingent consideration payment related to acquired business | (15,000) |  |  | — |
Other | (138) |  |  | (201) |
Net cash flows (used) by financing activities | (84,232) |  |  | (54,214) |
Effect of exchange rate changes on cash and cash equivalents | 10,805 |  |  | (8,154) |
Net change in cash and cash equivalents | (134,637) |  |  | (13,697) |
Cash and cash equivalents at beginning of period | 675,441 |  |  | 545,678 |
Cash and cash equivalents at end of period | $ | 540,804 |  |  | $ | 531,981 |

See accompanying notes to condensed consolidated financial statements.
4

FLOWSERVE CORPORATION
(Unaudited)
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
1.BASIS OF PRESENTATION AND ACCOUNTING POLICIES
Basis of Presentation
The accompanying condensed consolidated balance sheet as of March 31, 2025 and December 31, 2024, and the related condensed consolidated statements of income, condensed consolidated statements of comprehensive income (loss), condensed consolidated statements of shareholders' equity for the three months ended March 31, 2025 and 2024 and condensed consolidated statements of cash flows for the three months ended March 31, 2025 and 2024 of Flowserve Corporation are unaudited. In management’s opinion, all adjustments comprising normal recurring adjustments necessary for fair statement of such condensed consolidated financial statements have been made.
The accompanying condensed consolidated financial statements and notes in this Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2025 ("Quarterly Report") are presented as permitted by Regulation S-X and do not contain certain information included in our annual financial statements and notes thereto. Accordingly, the accompanying condensed consolidated financial information should be read in conjunction with the audited consolidated financial statements presented in our Annual Report on Form 10-K for the year ended December 31, 2024 ("2024 Annual Report").
Russia and Ukraine Conflict - In response to the Russia-Ukraine conflict, several countries, including the United States, have imposed economic sanctions and export controls on certain industry sectors and parties in Russia. As a result of this conflict, including the aforementioned sanctions and overall instability in the region, in March 2022 we permanently ceased all Company operations in Russia.
We continue to monitor the situation involving Russia and Ukraine and its impact on the rest of our global business. This includes the macroeconomic impact, including with respect to global supply chain issues and inflationary pressures. We reevaluated our financial exposure and made a $2 million adjustment during the period ended March 31, 2024 to reduce the existing reserves. We made no further adjustments through March 31, 2025. To date, impacts have not been material to our business and we do not currently expect that any incremental impact in future quarters, including any financial impacts caused by our cancellation of customer contracts and ceasing of operations in Russia, will be material to the Company.
Accounting Developments
Pronouncements Implemented
In August 2023, the FASB issued ASU No. 2023-05, "Business Combinations - Joint Venture Formations (Subtopic 805-60): Recognition and Initial Measurement." The amendments require that newly formed joint ventures measure the net assets and liabilities contributed at fair value. Subsequent measurement is in accordance with the requirements for acquirers of a business in Sections 805-10-35, 805-20-35, and 805-30-35, and other generally accepted accounting principles. The amendments were effective prospectively for all joint venture formations with a formation date on or after January 1, 2025, but companies may elect to apply the amendments retrospectively to joint ventures formed prior to January 1, 2025, if it has sufficient information. The adoption of this ASU did not have a material impact on the Company.
In December 2023, the FASB issued ASU No. 2023-08, "Intangibles - Goodwill and Other - Crypto Assets (Subtopic 350-60)." The amendments require that assets that qualify as a crypto asset, in accordance with the new guidance, must be recorded and subsequently valued at fair value at each reporting period, recognizing changes within net income of the same period. The amendments also require that companies present crypto assets measured at fair value separately from other intangible assets on the balance sheet with changes related to the remeasurement of crypto assets reported separately from changes in carrying amounts of other intangible assets in the income statement. Specific disclosure is required around the activity of crypto assets during the reporting period. The amendments were effective for all entities for fiscal years beginning after December 15, 2024, including interim periods within those fiscal years. The adoption of this ASU did not have a material impact on the Company as we do not own crypto assets.
Pronouncements Not Yet Implemented
In December 2023, the FASB issued ASU No. 2023-09, "Income Taxes (Topic 740)." The amendments require that entities on an annual basis disclose specific categories in the rate reconciliation, provide additional information for reconciling items that meet a quantitative threshold, and disclose specific information about income taxes paid. The amendments eliminate previously required disclosures around changes in unrecognized tax benefits and cumulative amounts of certain temporary differences. The amendments are effective prospectively for annual periods beginning after December 15, 2024. Early adoption is permitted. The amendments may be applied prospectively or retrospectively. We are evaluating the impact of this ASU on our disclosures.
5

In November 2024, the FASB issued ASU No. 2024-03, "Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40)." The amendments require disclosure of amounts, in the notes to financial statements, of purchases of inventory, employee compensation, depreciation, intangible asset amortization, and depletion for each income statement line item that contains those expenses. Specified expenses, gains and losses that are already disclosed under existing U.S. GAAP are also required to be included in the disaggregated income statement expense line item disclosure. The amendments also require disclosure of the total amount of selling expenses and the entity's definition of selling expenses. The amendments are effective for annual reporting periods beginning after December 15, 2026. ASU No. 2025-01 on the same topic issued in January 2025 further clarifies the effective date for interim periods. The amendments are effective for interim reporting periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The amendments may be applied prospectively or retrospectively. We are evaluating the impact of this ASU on our disclosures.
6

2. ACQUISITION
On October 15, 2024, we acquired for inclusion in the Flow Control Division ("FCD"), all of the equity interests of MOGAS Industries, Inc., MOGAS Real Estate LLC and MOGAS Systems & Consulting LLC (such entities collectively, "MOGAS"), for a purchase price of $290.0 million, subject to additional closing working capital adjustments of $13.0 million and net of cash acquired of $3.1 million, and an incremental contingent earn-out payment of $15.0 million which was paid in the first quarter of 2025. MOGAS, a privately held provider of mission-critical severe service valves and associated aftermarket services, is based in Houston, Texas and has operations primarily in North America and, to a lesser extent, Europe and Asia Pacific. The acquisition was funded using a combination of cash on hand and term loan financing under our Second Amended and Restated Credit Agreement discussed in Note 7, "Debt and Finance Lease Obligations." MOGAS's differentiated valve products are expected to enhance our installed base, creating meaningful aftermarket opportunities with the addition of MOGAS's strong brand, heritage, and technical expertise in diverse and attractive end markets, including the growing mining industry. The acquisition is accounted for as a business combination under Accounting Standards Codification 805, Business Combinations, using the acquisition method of accounting.
During the fourth quarter of 2024, the fair value of assets acquired and liabilities assumed was recorded on a preliminary basis as presented in Note 2, "Acquisition" in our consolidated financial statements included in our 2024 Annual Report. We did not record any measurement period adjustments during the first quarter of 2025. We continue to evaluate the initial fair values, which may be adjusted with an offsetting impact to goodwill, as additional information relative to the fair values of the assets and liabilities becomes available. The allocation of the purchase price remains preliminary as certain opening balance sheet accounts are subject to final working capital adjustments.
The excess of the acquisition date fair value of the total purchase price over the estimated fair value of the net assets was recorded as goodwill. Goodwill of $127.2 million represents the value expected to be obtained from expanding Flowserve's market presence and strengthening our portfolio of products and services through the addition of MOGAS's valve products. The goodwill related to this acquisition is recorded in the FCD segment and is expected to be fully deductible for tax purposes. The trademark is an indefinite-lived intangible. Existing customer relationships and backlog have expected weighted average useful lives of 10 years and one year, respectively. In total, amortizable intangible assets have a weighted average useful live of approximately 8 years. We recorded an indemnification asset and corresponding liability of $7.5 million related to unresolved legal matters that existed pre-acquisition, for which the seller has agreed to indemnify us. The indemnification asset and liability are included within prepaid expenses and other and accrued liabilities, respectively, in our condensed consolidated balance sheets. We incurred $1.3 million in acquisition and integration related costs for the three-month period ended March 31, 2025 associated with the acquisition which are included within selling, general and administrative expense ("SG&A") in our condensed consolidated statement of income.
7

3. REVENUE RECOGNITION
The majority of our revenues relate to customer orders that typically contain a single commitment of goods or services which have lead times under a year. More complex contracts with our customers typically have longer lead times and multiple commitments of goods and services, including any combination of designing, developing, manufacturing, modifying, installing and commissioning of flow management equipment and providing services and parts related to the performance of such products. Control transfers over time when the customer is able to direct the use of and obtain substantially all of the benefits of our work as we perform. Service-related revenues do not typically represent a significant portion of contracts with our customers and do not meet the thresholds requiring separate disclosure.
Revenue from products and services transferred to customers over time accounted for appro ximately 19% and 17% of total revenue for the three-month period ended March 31, 2025 and 2024, respectively. Our primary method for recognizing revenue over time is the percentage of completion ("POC") m ethod. If control does not transfer over time, then control transfers at a point in time. For both POC and point-in-time methods, we recognize revenue at the level of each performance obligation based on the evaluation of certain indicators of control transfer, such as title transfer, risk of loss transfer, customer acceptance and physical possession. Revenue from products and services transferred to customers at a point in time accounted for approximately 81% and 83% of total revenue for the three-month period ended March 31, 2025 and 2024, respectively. Refer to Note 3, "Revenue Recognition," to our consolidated financial statements included in our 2024 Annual Report for a more comprehensive discussion of our policies and accounting practices of revenue recognition.
Disaggregated Revenue
We conduct our operations through two business segments based on the type of product and how we manage the business:
•Flowserve Pumps Division ("FPD") designs, manufactures, pretests, distributes and services highly custom engineered pumps, pre-configured industrial pumps, pump systems, mechanical seals, auxiliary systems and replacement parts and related services; and
•FCD designs, manufactures and distributes a broad portfolio of engineered-to-order and configured-to-order isolation valves, control valves, valve automation products and related equipment.
Our revenue sources are derived from our original equipment manufacturing and our aftermarket sales and services. Our original equipment revenues are generally related to originally designed, manufactured, distributed and installed equipment that can range from pre-configured, short-cycle products to more customized, highly engineered equipment ("Original Equipment"). Our aftermarket sales and services are derived from sales of replacement equipment, as well as maintenance, advanced diagnostic, repair and retrofitting services ("Aftermarket"). Each of our two business segments generates Original Equipment and Aftermarket revenues.
The following tables present our customer revenues disaggregated by revenue source:

| Three Months Ended March 31, 2025
(Amounts in thousands) | FPD |  | FCD |  | Total
Original Equipment | $ | 280,230 |  |  | $ | 276,815 |  |  | $ | 557,045 |
Aftermarket | 501,259 |  |  | 86,239 |  |  | 587,498 |
| $ | 781,489 |  |  | $ | 363,054 |  |  | $ | 1,144,543 |
| Three Months Ended March 31, 2024
| FPD |  | FCD |  | Total
Original Equipment | $ | 285,038 |  |  | $ | 243,562 |  |  | $ | 528,600 |
Aftermarket | 483,725 |  |  | 75,154 |  |  | 558,879 |
| $ | 768,763 |  |  | $ | 318,716 |  |  | $ | 1,087,479 |

8

Our customer sales are diversified geographically. The following tables present our revenues disaggregated by geography, based on the shipping addresses of our customers:

| Three Months Ended March 31, 2025
(Amounts in thousands) | FPD |  | FCD |  | Total
North America(1) | $ | 327,327 |  |  | $ | 139,186 |  |  | $ | 466,513 |
Latin America(2) | 71,706 |  |  | 10,639 |  |  | 82,345 |
Middle East and Africa | 143,793 |  |  | 50,690 |  |  | 194,483 |
Asia Pacific | 97,213 |  |  | 105,507 |  |  | 202,720 |
Europe | 141,450 |  |  | 57,032 |  |  | 198,482 |
| $ | 781,489 |  |  | $ | 363,054 |  |  | $ | 1,144,543 |
| Three Months Ended March 31, 2024
| FPD |  | FCD |  | Total
North America(1) | $ | 310,469 |  |  | $ | 129,002 |  |  | $ | 439,471 |
Latin America(2) | 70,385 |  |  | 5,034 |  |  | 75,419 |
Middle East and Africa | 136,261 |  |  | 46,227 |  |  | 182,488 |
Asia Pacific | 106,294 |  |  | 76,447 |  |  | 182,741 |
Europe | 145,354 |  |  | 62,006 |  |  | 207,360 |
| $ | 768,763 |  |  | $ | 318,716 |  |  | $ | 1,087,479 |

_________________________________
(1) North America represents the United States and Canada.
(2) Latin America includes Mexico.
On March 31, 2025, the aggregate transaction price allocated to unsatisfied (or partially unsatisfied) performance obligations related to contracts having an original expected duration in excess of one year was approximately $962 million. We estimate recognition of approximately $535 million of this amount as revenue in the remainder of 2025 and an additional $427 million in 2026 and thereaft er.
Contract Balances
We receive payment from customers based on a contractual billing schedule and specific performance requirements as established in our contracts. We record billings as accounts receivable when an unconditional right to consideration exists. A contract asset represents revenue recognized in advance of our right to bill the customer under the terms of a contract. A contract liability represents our contractual billings in advance of revenue recognized for a contract.
9

The following tables present beginning and ending balances of contract assets and contract liabilities, current and long-term, for the three months ended March 31, 2025 and 2024:

(Amounts in thousands) | Contract Assets, net (Current) |  | Long-term Contract Assets, net(1) |  | Contract Liabilities (Current) |  | Long-term Contract Liabilities(2) |
Beginning balance, January 1, 2025 | $ | 298,906 |  |  | $ | 923 |  |  | $ | 283,670 |  |  | $ | 673 |  |
Revenue recognized that was included in contract liabilities at the beginning of the period | — |  |  | — |  |  | (119,775) |  |  | — |  |
Revenue recognized in the period in excess of billings | 145,721 |  |  | — |  |  | — |  |  | — |  |
Billings arising during the period in excess of revenue recognized | — |  |  | — |  |  | 118,078 |  |  | 1,348 |  |
Amounts transferred from contract assets to receivables | (128,844) |  |  | (768) |  |  | — |  |  | — |  |
Currency effects and other, net | (3,629) |  |  | 49 |  |  | 2,724 |  |  | 30 |  |
Ending balance, March 31, 2025 | $ | 312,154 |  |  | $ | 204 |  |  | $ | 284,697 |  |  | $ | 2,051 |  |

(Amounts in thousands) | Contract Assets, net (Current) |  | Long-term Contract Assets, net(1) |  | Contract Liabilities (Current) |  | Long-term Contract Liabilities(2)
Beginning balance, January 1, 2024 | $ | 280,228 |  |  | $ | 1,034 |  |  | $ | 287,697 |  |  | $ | 1,543 |
Revenue recognized that was included in contract liabilities at the beginning of the period | — |  |  | — |  |  | (101,602) |  |  | (295) |
Revenue recognized in the period in excess of billings | 166,318 |  |  | — |  |  | — |  |  | — |
Billings arising during the period in excess of revenue recognized | — |  |  | — |  |  | 90,523 |  |  | — |
Amounts transferred from contract assets to receivables | (156,948) |  |  | (713) |  |  | — |  |  | — |
Currency effects and other, net | (2,540) |  |  | 342 |  |  | 2,598 |  |  | (16) |
Ending balance, March 31, 2024 | $ | 287,058 |  |  | $ | 663 |  |  | $ | 279,216 |  |  | $ | 1,232 |

___________________________________
(1) Included in other assets, net.
(2) Included in retirement obligations and other liabilities.
4. ALLOWANCE FOR EXPECTED CREDIT LOSSES
The allowance for credit losses is an estimate of the credit losses expected over the life of our financial assets and instruments. We assess and measure expected credit losses on a collective basis when similar risk characteristics exist, including market, geography, credit risk and remaining duration. Financial assets and instruments that do not share risk characteristics are evaluated on an individual basis. Our estimate of the allowance is assessed and quantified using internal and external valuation information relating to past events, current conditions and reasonable and supportable forecasts over the contractual terms of an asset.
Our primary exposure to expected credit losses is through our accounts receivables and contract assets. For these financial assets, we record an allowance for expected credit losses that, when deducted from the gross asset balance, presents the net amount expected to be collected. Primarily, our experience of historical credit losses provides the basis for our estimation of the allowance. We estimate the allowance based on an aging schedule and according to historical losses as determined from our history of billings and collections. Additionally, we adjust the allowance for factors that are specific to our customers’ credit risk such as financial difficulties, liquidity issues, insolvency, and country and geopolitical risks. We also consider both the current and forecasted macroeconomic conditions as of the reporting date. As identified and needed, we adjust the allowance and recognize adjustments in the income statement each period. Accounts receivable are written off against the allowance in the period when the receivable is deemed to be uncollectible and further collection efforts have ceased. Subsequent recoveries of previously written off amounts are reflected as a reduction to credit impairment losses in the condensed consolidated statements of income.
10

Contract assets represent a conditional right to consideration for satisfied performance obligations that become a receivable when the conditions are satisfied. Generally, contract assets are recorded when contractual billing schedules differ from revenue recognition based on timing and are managed through the revenue recognition process. Based on our historical credit loss experience, the current expected credit loss for contract assets is estimated to be approxima tely 1% of the asset balance.
The following table presents the changes in the allowance for expected credit losses for our accounts receivables and short-term contract assets for the three months ended March 31, 2025 and 2024:

(Amounts in thousands) | Accounts receivables |  | Short-term contract assets
Beginning balance, January 1, 2025 | $ | 79,059 |  |  | $ | 3,404 |
Charges to cost and expenses, net of recoveries | 4,844 |  |  | 610 |
Write-offs | (158) |  |  | (8) |
Currency effects and other, net | 1,699 |  |  | (9) |
Ending balance, March 31, 2025 | $ | 85,444 |  |  | $ | 3,997 |
Beginning balance, January 1, 2024 | $ | 80,013 |  |  | $ | 4,993 |
Charges to cost and expenses, net of recoveries | 4,316 |  |  | — |
Write-offs | (4,642) |  |  | (10) |
Currency effects and other, net | (1,382) |  |  | 3 |
Ending balance, March 31, 2024 | $ | 78,305 |  |  | $ | 4,986 |

Our allowance on long-term receivables, included in other assets, net, represents receivables with collection periods longer than 12 months and the balance primarily consists of reserved receivables associated with the national oil company in Venezuela. The following table presents the changes in the allowance for long-term receivables for the three months ended March 31, 2025 and 2024:

(Amounts in thousands) | 2025 |  | 2024 |  |
Balance at January 1, | $ | 66,081 |  |  | $ | 66,864 |  |  |
Currency effects and other, net | (141) |  |  | (507) |  |  |
Balance at March 31, | $ | 65,940 |  |  | $ | 66,357 |  |  |

We also have exposure to credit losses from off-balance sheet exposures, such as financial guarantees and standby letters of credit, where we believe the risk of loss is immaterial to our financial statements as of March 31, 2025.
5. STOCK-BASED COMPENSATION PLANS
We maintain the Flowserve Corporation 2020 Long-Term Incentive Plan (“2020 Plan”), which is a shareholder approved plan authorizing the issuance of 12,500,000 shares of our common stock in the form of restricted shares, restricted share units and performance-based units (collectively referred to as "Restricted Shares"), incentive stock options, non-statutory stock options, stock appreciation rights and bonus stock. Of the shares of common stock authorized under the 2020 Plan, 5,935,142 were available for issuance as of March 31, 2025. Restricted Shares primarily vest over a three-year period. Restricted Shares granted to employees who retire and have achieved at least 55 years of age and 10 years of service continue to vest over the original vesting period ("55/10 Provision"). As of March 31, 2025, 114,943 stock options with a weighted average exercise price of $48.63 and a weighted average remaining contractual life of two years were outstanding and exercisable. No stock options have been granted or vested since 2020.
11

Restricted Shares – Awards of Restricted Shares are valued at the closing market price of our common stock on the date of grant. The unearned compensation is amortized to compensation expense over the vesting period of the restricted shares, except for awards related to the 55/10 Provision which are expensed in the period granted for awards issued prior to 2024. For awards of Restricted Shares granted beginning in 2024 and subject to the 55/10 Provision, compensation expense is recognized over a required six-month service period. We had unearned compensation of $47.3 million and $19.2 million at March 31, 2025 and December 31, 2024, which is expected to be recognized over a remaining weighted-average period of approximately two and one years, respectively. This amount will be recognized into net earnings in prospective periods as the awards vest. The total fair value of Restricted Shares vested during the three months ended March 31, 2025 and 2024 was $23.6 million and $25.7 million, respectively.
We awarded a one-time grant of approximately $5 million in the form of restricted shares to a group of employees during the first quarter of 2025 in conjunction with the freeze of our Company-sponsored qualified defined benefit pension plan in the United States. The restricted shares are subject to three-year cliff-vesting. Refer to Note 13, "Pension and Postretirement Benefits," to our condensed consolidated financial statements included in this Quarterly Report for further discussion.
We recorded stock-based compensation expense of $8.7 million ($6.7 million after-tax) for both the three months ended March 31, 2025 and 2024.
The following table summarizes information regarding Restricted Shares:

| Three Months Ended March 31, 2025
| Shares |  | Weighted Average Grant-Date Fair Value
Number of unvested shares: |  |  |
Outstanding as of January 1, 2025 | 1,666,683 |  |  | $ | 39.18 |
Granted | 606,931 |  |  | 62.72 |
Vested | (639,223) |  |  | 36.92 |
Forfeited | (15,344) |  |  | 47.58 |
Outstanding as of March 31, 2025 | 1,619,047 |  |  | $ | 48.82 |

Unvested Restricted Shares outstanding as of March 31, 2025 included approximately 515,000 units with performance-based vesting provisions issuable in common stock and vest upon the achievement of pre-defined performance metrics. Targets for outstanding performance awards are based on our annual return on invested capital and free cash flow as a percent of net income over a three-year period. Performance units issued in 2025, 2024 and 2023 include a secondary measure, relative total shareholder return, which can increase or decrease the number of vesting units by up to 15% depending on the Company's performance versus peers. Performance units issued have a vesting percentage up to 230%. Compensation expense is recognized ratably over a cliff-vesting period of 36 months, based on the fair value of our common stock on the date of grant, adjusted for actual forfeitures. During the performance period, earned and unearned compensation expense is adjusted based on changes in the expected achievement of the performance targets for all performance-based units granted. Vesting provisions range from 0 to approximately 1,185,000 shares based on performance targets. As of March 31, 2025, we estimate vesting of approximately 580,000 shares based on expected achievement of performance targets.
6. DERIVATIVES AND HEDGING ACTIVITIES
Our risk management and foreign currency derivatives and hedging policy specifies the conditions under which we may enter into derivative contracts. See Note 9, "Fair Value of Financial Instruments," for additional information on our derivatives. We enter into foreign exchange forward contracts to hedge our cash flow risks associated with transactions denominated in currencies other than the local currency of the operation engaging in the transaction. We have not elected hedge accounting for our foreign exchange forward contracts and the changes in the fair values are recognized immediately in our condensed consolidated statements of income.
Forei gn exchange forward contr acts with third parties had a notional value of $665.4 million and $695.9 million at March 31, 2025 and December 31, 2024, respectively. At March 31, 2025, the length of foreign exchange forward contracts currently in place ranged from 10 days to 16 months.
We are exposed to risk from credit-related losses resulting from non performance by counterparties to our financial instruments. We perform credit evaluations of our counterparties under foreign exchange forward contracts agreements and expect all counterparties to meet their obligations. We have not experienced credit losses from our counterparties.
The fair values of foreign exchange contracts are summarized below:

| March 31, |  | December 31,
(Amounts in thousands) | 2025 |  | 2024
Current derivative assets | $ | 1,964 |  |  | $ | 4,633 |
Noncurrent derivative assets | 202 |  |  | 13 |
Current derivative liabilities | 1,153 |  |  | 4,926 |
Noncurrent derivative liabilities | 101 |  |  | 374 |

Current and noncurrent derivative assets are reported in our condensed consolidated balance sheets in prepaid expenses and other and other assets, net, respectively. Current and noncurrent derivative liabilities are reported in our condensed consolidated balance sheets in accrued liabilities and retirement obligations and other liabilities, respectively.
The impact of net changes in the fair values of foreign exchange contracts are summarized below:

| Three Months Ended March 31, |  |
(Amounts in thousands) | 2025 |  | 2024 |  |  |  |
Gains (losses) recognized in income | $ | (4,551) |  |  | $ | 5,288 |  |  |  |  |

Gains and losses recognized in our condensed consolidated statements of income for foreign exchange forward contracts are classified as other income (expense), net.
7. DEBT AND FINANCE LEASE OBLIGATIONS
Debt, including finance lease obligations, net of discounts and debt issuance costs, consisted of:

| March 31, |  | December 31,
(Amounts in thousands, except percentages) | 2025 |  | 2024
3.50% USD Senior Notes due October 1, 2030, net of unamortized discount and debt issuance costs of $3,730 and $3,882, respectively | $ | 496,270 |  |  | $ | 496,118 |
2.80% USD Senior Notes due January 15, 2032, net of unamortized discount and debt issuance costs of $4,438 and $4,585, respectively | 495,562 |  |  | 495,415 |
Term Loan Facility, interest rate of 5.77% at March 31, 2025 and 5.80% at December 31, 2024, net of debt issuance costs of $928 and $993, respectively | 480,322 |  |  | 489,632 |
Finance lease obligations and other borrowings | 23,257 |  |  | 23,026 |
Debt and finance lease obligations | 1,495,411 |  |  | 1,504,191 |
Less amounts due within one year | 44,197 |  |  | 44,059 |
Total debt due after one year | $ | 1,451,214 |  |  | $ | 1,460,132 |

Senior Credit Facility
As discussed in Note 13, "Debt and Finance Lease Obligations," to our consolidated financial statements included in our 2024 Annual Report, our credit agreement (the "Senior Credit Agreement") provides a $800.0 million unsecured revolving credit facility (the "Revolving Credit Facility"), which includes a $750.0 million sublimit for the issuance of letters of credit and a $30.0 million sublimit for swing line loans, and a $300.0 million unsecured term loan facility (the "Term Loan") with a maturity date of September 13, 2026.
On February 3, 2023, we amended our Senior Credit Agreement (the “Amendment”) to (i) replace LIBOR with Secured Overnight Financing Rate (“SOFR”) as the benchmark reference rate, (ii) lower the Material Acquisition (as defined in the
Senior Credit Agreement) threshold from $250.0 million to $200.0 million and (iii) extend compliance dates for certain financial covenants.
On October 10, 2024, we entered into a Second Amended and Restated Credit Agreement (the "Second Amended and Restated Credit Agreement") with Bank of America, N.A., as administrative agent, and the other lenders (together, the "Lenders") and letter of credit issuers party thereto to (i) retain from the Senior Credit Agreement the $800.0 million Revolving Credit Facility, and the right, subject to certain conditions including Lenders approval of such increase, to increase the amount of such Revolving Credit Facility by an aggregate amount not to exceed $400.0 million, (ii) increase our Term Loan from $300.0 million to $500.0 million, and (iii) extend the maturity date to October 10, 2029. We believe this Second Amended and Restated Credit Agreement will provide greater flexibility and additional liquidity as we continue to pursue our business goals and strategy. Most other terms and conditions under the previous Senior Credit Agreement remained unchanged.
Under the terms and conditions of the Second Amended and Restated Credit Agreement, the interest rates per annum applicable to the Revolving Credit Facility and Term Loan, other than with respect to swing line loans, are adjusted Term Secured Overnight Financing Rate ("Adjusted Term SOFR") plus between 1.000% to 1.750%, depending on our debt rating by either Moody’s Investors Service, Inc. ("Moody's") or Standard & Poor’s Financial Services LLC ("S&P"), or, at our option, the Base Rate (as defined in the Second Amended and Restated Credit Agreement) plus between 0.000% to 0.750% depending on our debt rating by either Moody’s or S&P. At March 31, 2025, the interest rate on the Revolving Credit Facility was the Adjusted Term SOFR plu s 1.375% in the case of Adjusted Term SOFR loans and the Base Rate plus 0.375% in the case of Base Rate loans. In addition, a commitment fee is payable quarterly in arrears on the daily unused portions of the Revolving Credit Facility. The commitment fee will be between 0.080% and 0.250% of unused amounts under the Revolving Credit Facility depending on our debt rating by either Moody’s or S&P. The commitment fee was 0.175% (per annum) during the period ended March 31, 2025. At March 31, 2025, the interest rate on the Term Loan was Adjusted Term SOFR plus 1.375% in the case of Adjusted Term SOFR loans and the Base Rate plus 0.375% in the case of Base Rate loans.
As of March 31, 2025 and December 31, 2024, we had no revolving loans outstanding and we had outstanding letters of credit of $137.8 million and $144.0 million, respectively. After consideration of the outstanding letters of credit as of March 31, 2025, the amount available for borrowings under our Revolving Credit Facility was limited to $662.2 million. As of December 31, 2024, the amount available for borrowings under our Revolving Credit Facility was $656.0 million. We have scheduled repayments of $9.4 million due in each of the next four quarters on our Term Loan.
Our compliance with applicable financial covenants under the Second Amended and Restated Credit Agreement are test ed quarterly. We were in compliance with all applicable covenants as of March 31, 2025.
12

8. SUPPLIER FINANCE PROGRAMS
We partner with two banks to offer our suppliers the option of participating in a supplier financing program and receive payment early. Under the program agreement, we must reimburse each bank for approved and valid invoices in accordance with the originally agreed upon terms with the supplier. We have no obligation for fees; subscription, service, commissions or otherwise with either bank. We also have no obligation for pledged assets or other forms of guarantee and may terminate either program agreement with appropriate notice. As of March 31, 2025 and December 31, 2024, $12.0 million and $8.6 million, respectively, remained outstanding with the supply chain financing partner banks and recorded within accounts payable on our condensed consolidated balance sheets.
13

9. FAIR VALUE OF FINANCIAL INSTRUMENTS
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Where available, fair value is based on observable market prices or parameters or derived from such prices or parameters. Where observable prices or inputs are not available, valuation models may be applied. Assets and liabilities recorded at fair value in our condensed consolidated balance sheets are categorized by hierarchical levels based upon the level of judgment associa ted with the inputs used to measure their fair values. Recurring fair value measurements are limited to investments in derivative instruments and contingent consideration arising from the recently completed MOGAS acquisition which existed at December 31, 2024. The fair value measurements of our derivative instruments are determined using models that maximize the use of the observable market inputs including interest rate curves and both forward and spot prices for currencies, and are classified as Level II under the fair value hierarchy. The fair values of our derivatives are included in Note 6, "Derivatives and Hedging Activities." The fair value of the MOGAS related contingent consideration was determined based on contractual provisions set forth in the purchase agreement and was fully paid in the first quarter of 2025.
The carrying value of our financial instruments as reflected in our condensed consolidated balance sheets approximates fair value, with the exception of our long-term debt. The estimated fair value of our long-term debt, excluding the Senior Notes, approximat es the carrying value and is determined using Level II inputs under the fair value hier archy. The carrying value of our debt is included in Note 7, "Debt and Finance Lease Obligations." The estimated fair value of our Senior Notes at March 31, 2025 was $889.7 million c ompared to the carrying value of $991.8 million. The estimated fair value of the Senior Notes is based on Level I quoted market rates. The carrying amounts of our other financial instruments (e.g., cash and cash equivalents, accounts receivable, net, accounts payable and short-term debt) appr oximated fair value due to their short-term nature at March 31, 2025 and December 31, 2024.
10. INVENTORIES
Inventories consisted of the following:

| March 31, |  | December 31,
(Amounts in thousands) | 2025 |  | 2024
Raw materials | $ | 392,622 |  |  | $ | 391,562 |
Work in process | 276,769 |  |  | 262,173 |
Finished goods | 269,994 |  |  | 275,975 |
Less: Excess and obsolete reserve | (97,839) |  |  | (92,456) |
Inventories | $ | 841,546 |  |  | $ | 837,254 |

14

11. EARNINGS PER SHARE
The following is a reconciliation of net earnings of Flowserve Corporation and weighted average shares for calculating net earnings per common share. Earnings per weighted average common share outstanding was calculated as follows:

| Three Months Ended March 31,
(Amounts in thousands, except per share data) | 2025 |  | 2024
Net earnings attributable to Flowserve Corporation | $ | 73,905 |  |  | $ | 74,220 |
Dividends on restricted shares not expected to vest | — |  |  | — |
Earnings attributable to common and participating shareholders | $ | 73,905 |  |  | $ | 74,220 |
Weighted average shares: |  |  |
Common stock | 131,534 |  |  | 131,464 |
Participating securities | 32 |  |  | 46 |
Denominator for basic earnings per common share | 131,566 |  |  | 131,510 |
Effect of potentially dilutive securities | 1,104 |  |  | 858 |
Denominator for diluted earnings per common share | 132,670 |  |  | 132,368 |
Earnings per common share: |  |  |
Basic | $ | 0.56 |  |  | $ | 0.56 |
Diluted | 0.56 |  |  | 0.56 |

Diluted earnings per share above is based upon the weighted average number of shares as determined for basic earnings per share plus shares potentially issuable in conjunction with stock options and Restricted Shares.
12. LEGAL MATTERS AND CONTINGENCIES
Asbestos-Related Claims
We are a defendant in a substantial number of lawsuits that seek to recover damages for personal injury allegedly caused by exposure to asbestos-containing products manufactured and/or distributed by our heritage companies in the past. Typically, these lawsuits have been brought against multiple defendants in state and federal courts. While the overall number of asbestos-related claims in which we or our predecessors have been named has generally declined in recent years, the number of new claims may fluctuate or increase between periods, and there can be no assurance that total outstanding claims will continue to decline, or that the average cost per claim to us will not further increase. Asbestos-containing materials incorporated into any such products were encapsulated and used as internal components of process equipment, and we do not believe that significant emission of asbestos fibers occurred during the use of this equipment.
Our practice is to vigorously contest and resolve these claims, and we have been successful in resolving a majority of claims with little or no payment, other than legal fees. Activity related to asbestos claims during the periods indicated was as follows:

| Three Months Ended March 31, |  |  |
| 2025 |  | 2024 |  |  |  |  |
Beginning claims(1) | 8,127 |  |  | 8,236 |  |  |  |  |  |
New claims | 698 |  |  | 617 |  |  |  |  |  |
Resolved claims | (674) |  |  | (847) |  |  |  |  |  |
Other(2) | (20) |  |  | 219 |  |  |  |  |  |
Ending claims(1) | 8,131 |  |  | 8,225 |  |  |  |  |  |

____________________
(1) Beginning and ending claims data in each period excludes inactive claims, as the Company assumes that inactive cases will not be pursued further by the respective plaintiffs. A claim is classified as inactive either due to inactivity over a period of time or if designated as inactive by the applicable court.
15

(2) Represents the net change in claims as a result of the reclassification of active cases as inactive and inactive cases as active during the period indicated. Cases moved from active to inactive status are removed from the claims count without being accounted for as a "Resolved claim", and cases moved from inactive status to active status are added back to the claims count without being accounted for as a “New claim.”
The following table presents the changes in the estimated asbestos liability:

(Amounts in thousands) | 2025 |  | 2024
Beginning balance, January 1, | $ | 110,332 |  |  | $ | 102,903 |
Cash payment activity | (2,349) |  |  | (1,919) |
Other, net | (2,957) |  |  | (1,592) |
Ending balance, March 31, | $ | 105,026 |  |  | $ | 99,392 |

During the three months ended March 31, 2025 and 2024, the Company incurred expenses (net of insurance) of approximately $2.0 million and $1.8 million, respectively, to defend, resolve or otherwise dispose of outstanding claims, including legal and other related expenses. These expenses are included within SG&A in our condensed consolidated statements of income.
The Company had cash inflows/(outflows) (net of insurance and/or indemnity) to defend, resolve or otherwise dispose of outstanding claims, including legal and other related expenses of approximately $(4.3) million and $(3.7) million, respectively, during the three months ended March 31, 2025 and 2024, respectively.
Historically, a high percentage of resolved claims have been covered by applicable insurance or indemnities from other companies, and we believe that a portion of existing claims should continue to be covered by insurance or indemnities, in whole or in part.
We believe that our reserve for asbestos claims and the receivable for recoveries from insurance carriers that we have recorded for these claims reflect reasonable and probable estimates of these amounts. Our estimate of our ultimate exposure for asbestos claims, however, is subject to significant uncertainties, including the timing and number and types of new claims, unfavorable court rulings, judgments or settlement terms and ultimate costs to settle. Additionally, the continued viability of carriers may also impact the amount of probable insurance recoveries. We believe that these uncertainties could have a material adverse impact on our business, financial condition, results of operations and cash flows, though we currently believe the likelihood is remote.
Additionally, we have claims pending against certain insurers that, if in future periods are resolved more favorably than reflected in the recorded receivables, would result in discrete gains in the applicable quarter.
Other
We are also a defendant in a number of other lawsuits, including product liability claims, that are insured, subject to the applicable deductibles, arising in the ordinary course of business, and we are also involved in other uninsured routine litigation incidental to our business. We currently believe none of such litigation, either individually or in the aggregate, is material to our business, operations or overall financial condition. However, litigation is inherently unpredictable, and resolutions or dispositions of claims or lawsuits by settlement or otherwise could have an adverse impact on our financial position, results of operations or cash flows for the reporting period in which any such resolution or disposition occurs.
Although none of the aforementioned potential liabilities can be quantified with absolute certainty except as otherwise indicated above, we have established or adjusted reserves covering exposures relating to contingencies, to the extent believed to be reasonably estimable and probable based on past experience and available facts. While additional exposures beyond these reserves could exist, they currently cannot be estimated. We will continue to evaluate and update the reserves as necessary and appropriate.
16

13. PENSION AND POSTRETIREMENT BENEFITS
Components of the net periodic cost for pension and postretirement benefits for the three months ended March 31, 2025 and 2024 were as follows:

| U.S. Defined Benefit Plans |  | Non-U.S. Defined Benefit Plans |  | Postretirement Medical Benefits
(Amounts in millions) | 2025 |  | 2024 |  | 2025 |  | 2024 |  | 2025 |  | 2024
Service cost | $ | 0.2 |  |  | $ | 5.7 |  |  | $ | 1.5 |  |  | $ | 1.3 |  |  | $ | — |  |  | $ | — |
Interest cost | 5.6 |  |  | 5.4 |  |  | 3.2 |  |  | 3.0 |  |  | 0.2 |  |  | 0.2 |
Expected return on plan assets | (6.0) |  |  | (6.0) |  |  | (2.0) |  |  | (1.9) |  |  | — |  |  | — |
Settlement loss (1) | 1.5 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Amortization of unrecognized prior service cost and other costs | 0.1 |  |  | — |  |  | 0.2 |  |  | 0.1 |  |  | — |  |  | — |
Amortization of unrecognized net loss | 0.1 |  |  | — |  |  | 0.5 |  |  | 0.6 |  |  | — |  |  | — |
Net periodic cost recognized | $ | 1.5 |  |  | $ | 5.1 |  |  | $ | 3.4 |  |  | $ | 3.1 |  |  | $ | 0.2 |  |  | $ | 0.2 |

____________________
(1) Represents a pension settlement accounting loss incurred in conjunction with the freeze of our Company-sponsored qualified defined benefit pension plan in the United States (the "Qualified Plan") for non-union employees. Full year cash outflows are expected to exceed the service and interest cost components and trigger a settlement loss later in 2025 in the range of $6 million - $7 million. The first quarter loss was recorded based on this full year estimate.
The components of net periodic cost for pension and postretirement benefits other than service costs are included in other income (expense), net in our condensed consolidated statements of income.
In August 2023, we amended the Company-sponsored Qualified Plan for non-union employees to discontinue future benefit accruals under the Qualified Plan and freeze existing accrued benefits effective January 1, 2025. Benefits earned by participants under the Qualified Plan prior to January 1, 2025, are not affected. We also amended the Company-sponsored non-qualified defined benefit pension plan in the United States (the "Non-Qualified Plan") that provides enhanced retirement benefits to select members of management. The Qualified Plan and the Non-Qualified Plan were closed to new entrants effective January 1, 2024, and September 1, 2023, respectively. The amendments resulted in a curtailment of both plans, and the curtailment loss incurred and the change in projected benefit obligation was immaterial.
In conjunction with the amendment of the Qualified Plan, the Organization and Compensation Committee of our Board of Directors approved certain transition benefits associated with freezing the Qualified Plan. During the first quarter of 2025, a one-time cash transition benefit was paid to a limited group of employees in the United States that met certain criteria. We recorded a $5.0 million liability for this obligation prior to payment which is included within accrued liabilities in our condensed consolidated balance sheet at December 31, 2024. We also issued approximately the same amount of value in the form of restricted shares to an additional group of employees in the United States during the first quarter of 2025. The restricted shares are subject to three-year cliff-vesting.
14. SHAREHOLDERS' EQUITY
Dividends – Generally, our dividend date-of-record is in the last month of the quarter, and the dividend is paid the following month. Any subsequent dividends will be reviewed by our Board of Directors and declared in its discretion.
Dividends declared per share were as follows:

| Three Months Ended March 31, |  |
| 2025 |  | 2024 |  |  |  |
Dividends declared per share | $ | 0.21 |  |  | $ | 0.21 |  |  |  |  |

Share Repurchase Program – In 2014, our Board of Directors approved a $500.0 million share repurchase authorization. As of December 31, 2023, we had $96.1 million of remaining capacity under the prior share repurchase authorization. Effective February 19, 2024, the Board of Directors approved an increase in our total remaining capacity under the share repurchase program to $300.0 million. Our share repurchase program does not have an expiration date and we reserve the right to limit or terminate the repurchase program at any time without notice.
17

We repurchased 427,574 shares of our outstanding common stock for $21.1 million and 57,000 shares of our outstanding common stock for $2.5 million during the three months ended March 31, 2025, and 2024, respectively. As of March 31, 2025, we had $258.8 million of remaining capacity under our current share repurchase program.
15. INCOME TAXES
For the three months ended March 31, 2025, we earned $97.2 million before taxes and recorded a provision for income taxes of $17.7 million resulting in an effective tax rate of 18.3%. The effective tax rate varied from the U.S. federal statutory rate for the three months ended March 31, 2025 primarily due to the net impact of U.S. discrete items, partially offset by state income taxes.
For the three months ended March 31, 2024, we earned $98.1 million before taxes and recorded a provision for income taxes of $20.1 million resulting in an effective tax rate of 20.5%. The effective tax rate varied from the U.S. federal statutory rate for the three months ended March 31, 2024 primarily due to the net impact of foreign operations and state income taxes.
The Company maintains a full valuation allowance against the net deferred tax assets in certain foreign tax jurisdictions as of March 31, 2025. As of each reporting date, management considers new evidence, both positive and negative, that could affect its view of the future realization of net deferred tax assets. We assess our forecast of future taxable income and available tax planning strategies that could be implemented to realize the net deferred tax assets in determining the sufficiency of our valuation allowances. Failure to achieve forecasted taxable income in the applicable tax jurisdictions could affect the ultimate realization of deferred tax assets and could result in an increase in our effective tax rate on future earnings. It is possible there may be sufficient positive evidence to release a portion of the remaining valuation allowance in those foreign jurisdictions. Release of the valuation allowance would result in a benefit to income tax expense for the period the release is recorded, which could have a material impact on net earnings. The timing and amount of the potential valuation allowance release are subject to significant management judgment and the level of profitability achieved.
On December 20, 2021, the Organisation for Economic Co-operation and Development (“OECD”) released the Model GloBE Rules for Pillar Two defining a 15% global minimum tax rate for large multinational corporations. Many countries continue to consider changes in their tax laws and regulations based on the Pillar Two proposals. We are continuing to evaluate the impact of these proposed and enacted legislative changes as new guidance becomes available. Some of these legislative changes could result in double taxation of our non-U.S. earnings, a reduction in the tax benefit received from our tax incentives, or other impacts to our effective tax rate and tax liabilities. As of March 31, 2025, the company is not expecting material impacts under currently enacted legislation.
18

16. BUSINESS SEGMENT INFORMATION
The following is a summary of the financial information of the reportable segments reconciled to the amounts reported in the condensed consolidated financial statements:

| Three Months Ended March 31, 2025
(Amounts in thousands) | FPD |  | FCD |  | Subtotal–Reportable Segments |  | Eliminations and All Other |  | Consolidated Total
Sales to external customers | $ | 781,489 |  |  | $ | 363,054 |  |  | $ | 1,144,543 |  |  | $ | — |  |  | $ | 1,144,543 |
Intersegment sales | 1,651 |  |  | 1,052 |  |  | 2,703 |  |  | (2,703) |  |  | — |
Cost of Sales | (514,678) |  |  | (263,919) |  |  | (778,597) |  |  |  |  |
Selling, general and administrative expense | (137,680) |  |  | (68,705) |  |  | (206,385) |  |  |  |  |
Other Segment items (1) | 5,732 |  |  | — |  |  | 5,732 |  |  |  |  |
Segment operating income | 136,515 |  |  | 31,482 |  |  | 167,997 |  |  |  |  |
Depreciation and amortization | 9,795 |  |  | 9,743 |  |  | 19,538 |  |  | 4,864 |  |  | 24,402 |
Identifiable assets | 3,159,095 |  |  | 1,770,584 |  |  | 4,929,679 |  |  | 553,619 |  |  | 5,483,298 |
Capital expenditures | 6,944 |  |  | 2,296 |  |  | 9,240 |  |  | 2,498 |  |  | 11,738 |
| Three Months Ended March 31, 2024
| FPD |  | FCD |  | Subtotal–Reportable Segments |  | Eliminations and All Other |  | Consolidated Total
Sales to external customers | $ | 768,763 |  |  | $ | 318,716 |  |  | $ | 1,087,479 |  |  | $ | — |  |  | $ | 1,087,479 |
Intersegment sales | 637 |  |  | 1,802 |  |  | 2,439 |  |  | (2,439) |  |  | — |
Cost of Sales | (521,462) |  |  | (227,823) |  |  | $ | (749,285) |  |  |  |  |
Selling, general and administrative expense | (139,710) |  |  | (57,987) |  |  | (197,697) |  |  |  |  |
Other Segment items (1) | 2,666 |  |  | — |  |  | $ | 2,666 |  |  |  |  |
Segment operating income | 110,894 |  |  | 34,708 |  |  | 145,602 |  |  |  |  |
Depreciation and amortization | 11,425 |  |  | 4,953 |  |  | 16,378 |  |  | 5,202 |  |  | 21,580 |
Identifiable assets | 3,231,614 |  |  | 1,333,677 |  |  | 4,565,291 |  |  | 584,634 |  |  | 5,149,925 |
Capital expenditures | 9,823 |  |  | 2,327 |  |  | 12,150 |  |  | 1,460 |  |  | 13,610 |

__________________
(1) Other Segment items comprises Net Earnings from Affiliates.
19

The following are reconciliations from total segment operating income to earnings before income tax reported in the condensed consolidated income statements.

| Three Months Ended March 31,
| 2025 |  | 2024
| (Amounts in thousands)
Total segment operating income (loss) | $ | 167,997 |  |  | $ | 145,602 |
Intersegment sales | (2,703) |  |  | (2,439) |
Eliminations and all other cost of sales | 3,387 |  |  | 774 |
Eliminations and all other SG&A | (36,792) |  |  | (30,721) |
Interest expense | (19,175) |  |  | (15,317) |
Interest income | 1,745 |  |  | 1,169 |
Net earnings (loss) from affiliates | — |  |  | (137) |
Other income (expense), net | (17,259) |  |  | (874) |
Earnings before income taxes | 97,200 |  |  | 98,057 |

20

17. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
The following table presents the changes in Accumulated Other Comprehensive Loss ("AOCL"), net of related tax effects for the three months ended March 31, 2025 and 2024:

| 2025 |  | 2024
(Amounts in thousands) | Foreign currency translation items(1) |  | Pension and other post-retirement effects |  | Cash flow hedging activity (2) |  | Total |  | Foreign currency translation items(1) |  | Pension and other post-retirement effects |  | Cash flow hedging activity (2) |  | Total
Balance - January 1, | $ | (632,097) |  |  | $ | (115,898) |  |  | $ | (747) |  |  | $ | (748,742) |  |  | $ | (523,873) |  |  | $ | (121,882) |  |  | $ | (813) |  |  | $ | (646,568) |
Other comprehensive income (loss) before reclassifications (3) | 47,571 |  |  | (1,534) |  |  | — |  |  | 46,037 |  |  | (28,244) |  |  | 517 |  |  | — |  |  | (27,727) |
Amounts reclassified from AOCL | — |  |  | 1,868 |  |  | 24 |  |  | 1,892 |  |  | — |  |  | 859 |  |  | (5) |  |  | 854 |
Net current-period other comprehensive income (loss) (3) | 47,571 |  |  | 334 |  |  | 24 |  |  | 47,929 |  |  | (28,244) |  |  | 1,376 |  |  | (5) |  |  | (26,873) |
Balance - March 31, | $ | (584,526) |  |  | $ | (115,564) |  |  | $ | (723) |  |  | $ | (700,813) |  |  | $ | (552,117) |  |  | $ | (120,506) |  |  | $ | (818) |  |  | $ | (673,441) |

________________________________
(1) Includes foreign currency translation adjustments attributable to noncontrolling interests of $(7.3) million and $(7.0) million at January 1, 2025 and 2024, respectively, and $(7.3) million and $(7.2) million at March 31, 2025 and 2024, respectively.
(2) Other comprehensive loss before reclassifications and amounts reclassified from AOCL to interest expense related to designated cash flow hedges.
(3) Amounts in parentheses indicate an increase to AOCL.
The following table presents the reclassifications out of AOCL:

|  |  |  | Three Months Ended March 31,
(Amounts in thousands) |  | Affected line item in the statement of income |  | 2025(1) |  | 2024(1)
Pension and other postretirement effects |  |  |  |  |  |
Amortization of actuarial losses(2) |  | Other income (expense), net |  | $ | (603) |  |  | $ | (630) |
Prior service costs(2) |  | Other income (expense), net |  | (152) |  |  | (153) |
Settlements and other(2) |  | Other income (expense), net |  | (1,500) |  |  | — |
|  | Tax benefit (expense) |  | 387 |  |  | (76) |
|  | Net of tax |  | $ | (1,868) |  |  | $ | (859) |
Cash flow hedging activity |  |  |  |  |  |
Amortization of Treasury rate lock |  | Interest income (expense) |  | $ | (31) |  |  | $ | (30) |
|  | Tax benefit (expense) |  | 7 |  |  | 35 |
|  | Net of tax |  | $ | (24) |  |  | $ | 5 |

__________________________________
(1) Amounts in parentheses indicate decreases to income. None of the reclassified amounts have a noncontrolling interest component.
(2) These AOCL components are included in the computation of net periodic pension cost. See Note 13, "Pension and Postretirement Benefits," for additional details.
21

18. REALIGNMENT PROGRAMS
In the first quarter of 2023, we identified and initiated certain realignment activities concurrent with the consolidation of our FPD aftermarket and pump operations into a single operating model. This consolidated operating model was designed to better align our go-to-market strategy with our product offerings, enable end-to-end lifecycle responsibility and accountability, and to facilitate more efficient operations. During 2023, we also initiated certain product and portfolio optimization activities. Collectively, the above realignment activities are referred to as the "2023 Realignment Programs." The activities of the 2023 Realignment Programs were identified and implemented in phases throughout 2023 and 2024 and are substantially completed.
In the fourth quarter of 2024, we launched the complexity reduction ("CORE") program within the portfolio excellence category of the Flowserve Business System. The CORE program focuses on product rationalization and continuous improvement of our overall product portfolio. During 2025, we also initiated certain other portfolio and footprint optimization activities. These optimization activities together with the CORE program, are referred to as the "2025 Realignment Programs." We currently anticipate a total investment in the 2025 Realignment Programs, which have been evaluated and initiated, of approximately $23 million of which $8 million is estimated to be non-cash. We are evaluating the annualized cost savings expected to be achieved upon completion of the activities of the 2025 Realignment Programs that have been identified and initiated to date. Actual savings could vary from expected savings.
The realignment activities consist of restructuring and non-restructuring charges. Restructuring charges represent costs associated with the relocation of certain business activities and facility closures and include related severance costs. Non-restructuring charges are primarily employee severance associated with the workforce reductions and professional service fees. Expenses are primarily reported in cost of sales ("COS") or SG&A, as applicable, in our condensed consolidated statements of income. There are certain remaining realignment activities that are currently being evaluated, but have not yet been approved and therefore are not included in the above anticipated total investment.
Generally, the aforementioned charges will be paid in cash, except for asset write-downs, which are non-cash charges. The following is a summary of total charges, net of adjustments, incurred related to our realignment activities:

| Three Months Ended March 31, 2025
(Amounts in thousands) | FPD |  | FCD |  | Subtotal–Reportable Segments |  | All Other |  | Consolidated Total
Realignment Charges |  |  |  |  |  |  |  |  |
Restructuring Charges |  |  |  |  |  |  |  |  |
COS | $ | 3,616 |  |  | $ | 7,109 |  |  | $ | 10,725 |  |  | $ | — |  |  | $ | 10,725 |
SG&A | 106 |  |  | — |  |  | 106 |  |  | — |  |  | 106 |
| $ | 3,722 |  |  | $ | 7,109 |  |  | $ | 10,831 |  |  | $ | — |  |  | $ | 10,831 |
Non-Restructuring Charges |  |  |  |  |  |  |  |  |
COS | $ | (637) |  |  | $ | (8) |  |  | $ | (645) |  |  | $ | (66) |  |  | $ | (711) |
SG&A | (1,103) |  |  | (121) |  |  | (1,224) |  |  | (185) |  |  | (1,409) |
| $ | (1,740) |  |  | $ | (129) |  |  | $ | (1,869) |  |  | $ | (251) |  |  | $ | (2,120) |
Total Realignment Charges |  |  |  |  |  |  |  |  |
COS | $ | 2,979 |  |  | $ | 7,101 |  |  | $ | 10,080 |  |  | $ | (66) |  |  | $ | 10,014 |
SG&A | (997) |  |  | (121) |  |  | (1,118) |  |  | (185) |  |  | (1,303) |
Total | $ | 1,982 |  |  | $ | 6,980 |  |  | $ | 8,962 |  |  | $ | (251) |  |  | $ | 8,711 |

22

| Three Months Ended March 31, 2024
(Amounts in thousands) | FPD |  | FCD |  | Subtotal–Reportable Segments |  | All Other |  | Consolidated Total
Realignment Charges |  |  |  |  |  |  |  |  |
Restructuring Charges |  |  |  |  |  |  |  |  |
COS | $ | 4,414 |  |  | $ | 15 |  |  | $ | 4,429 |  |  | $ | — |  |  | $ | 4,429 |
SG&A | 701 |  |  | — |  |  | 701 |  |  | — |  |  | 701 |
| $ | 5,115 |  |  | $ | 15 |  |  | $ | 5,130 |  |  | $ | — |  |  | $ | 5,130 |
Non-Restructuring Charges |  |  |  |  |  |  |  |  |
COS | $ | 630 |  |  | $ | 752 |  |  | $ | 1,382 |  |  | $ | (138) |  |  | $ | 1,244 |
SG&A | 340 |  |  | 114 |  |  | 454 |  |  | 339 |  |  | 793 |
| $ | 970 |  |  | $ | 866 |  |  | $ | 1,836 |  |  | $ | 201 |  |  | $ | 2,037 |
Total Realignment Charges |  |  |  |  |  |  |  |  |
COS | $ | 5,044 |  |  | $ | 767 |  |  | $ | 5,811 |  |  | $ | (138) |  |  | $ | 5,673 |
SG&A | 1,041 |  |  | 114 |  |  | 1,155 |  |  | 339 |  |  | 1,494 |
Total | $ | 6,085 |  |  | $ | 881 |  |  | $ | 6,966 |  |  | $ | 201 |  |  | $ | 7,167 |

The following is a summary of total inception to date charges, net of adjustments, related to the 2025 Realignment Programs:

| Inception to Date
(Amounts in thousands) | FPD |  | FCD |  | Subtotal–Reportable Segments |  | All Other |  | Consolidated Total
Realignment Charges |  |  |  |  |  |  |  |  |
Restructuring Charges |  |  |  |  |  |  |  |  |
COS | $ | 3,616 |  |  | $ | 7,109 |  |  | $ | 10,725 |  |  | $ | — |  |  | $ | 10,725 |
SG&A | 106 |  |  | — |  |  | 106 |  |  | — |  |  | 106 |
| $ | 3,722 |  |  | $ | 7,109 |  |  | $ | 10,831 |  |  | $ | — |  |  | $ | 10,831 |
Non-Restructuring Charges |  |  |  |  |  |  |  |  |
COS | $ | 2,305 |  |  | $ | (8) |  |  | $ | 2,297 |  |  | $ | (66) |  |  | $ | 2,231 |
SG&A(1) | (1,103) |  |  | (121) |  |  | (1,224) |  |  | (185) |  |  | (1,409) |
| $ | 1,202 |  |  | $ | (129) |  |  | $ | 1,073 |  |  | $ | (251) |  |  | $ | 822 |
Total Realignment Charges |  |  |  |  |  |  |  |  |
COS | $ | 5,921 |  |  | $ | 7,101 |  |  | $ | 13,022 |  |  | $ | (66) |  |  | $ | 12,956 |
SG&A | (997) |  |  | (121) |  |  | (1,118) |  |  | (185) |  |  | (1,303) |
Total | $ | 4,924 |  |  | $ | 6,980 |  |  | $ | 11,904 |  |  | $ | (251) |  |  | $ | 11,653 |

(1) Includes the immaterial reversal of previously recognized realignment charges associated with our 2023 Realignment Programs, which was recognized in the first quarter of 2025. Our 2023 Realignment Programs are substantially completed.
The following is a summary of total inception to date charges, net of adjustments, related to the 2023 Realignment Programs:
23

| Inception to Date
(Amounts in thousands) | FPD |  | FCD |  | Subtotal–Reportable Segments |  | All Other |  | Consolidated Total
Realignment Charges |  |  |  |  |  |  |  |  |
COS | $ | 27,076 |  |  | $ | 5,041 |  |  | $ | 32,117 |  |  | $ | 66 |  |  | $ | 32,183 |
SG&A | 1,355 |  |  | 12,376 |  |  | 13,731 |  |  | (28) |  |  | 13,703 |
Loss on sale of business(1) | — |  |  | 12,981 |  |  | 12,981 |  |  | — |  |  | 12,981 |
| $ | 28,431 |  |  | $ | 30,398 |  |  | $ | 58,829 |  |  | $ | 38 |  |  | $ | 58,867 |
Non-Restructuring Charges |  |  |  |  |  |  |  |  |
COS | $ | 11,506 |  |  | $ | 6,612 |  |  | $ | 18,118 |  |  | $ | (655) |  |  | $ | 17,463 |
SG&A | 14,256 |  |  | 2,112 |  |  | 16,368 |  |  | 19,893 |  |  | $ | 36,261 |
| $ | 25,762 |  |  | $ | 8,724 |  |  | $ | 34,486 |  |  | $ | 19,238 |  |  | $ | 53,724 |
Total Realignment Charges |  |  |  |  |  |  |  |  |
COS | $ | 38,582 |  |  | $ | 11,653 |  |  | $ | 50,235 |  |  | $ | (589) |  |  | $ | 49,646 |
SG&A | 15,611 |  |  | 14,488 |  |  | 30,099 |  |  | 19,865 |  |  | $ | 49,964 |
Loss on sale of business(1) | — |  |  | 12,981 |  |  | 12,981 |  |  | — |  |  | $ | 12,981 |
Total | $ | 54,193 |  |  | $ | 39,122 |  |  | $ | 93,315 |  |  | $ | 19,276 |  |  | $ | 112,591 |

(1) Loss on sale of business related to NAF AB control valves business as described within Note 1, "Significant Accounting Policies and Accounting Developments," to our consolidated financial statements included in our 2024 Annual Report.
Restructuring charges represent costs associated with the relocation or reorganization of certain business activities and facility closures and include costs related to employee severance at closed facilities, contract termination costs, asset write-downs and other costs. Severance costs primarily include costs associated with involuntary termination benefits. Contract termination costs include costs related to the termination of operating leases or other contract termination costs. Asset write-downs include accelerated depreciation of fixed assets, accelerated amortization of intangible assets, divestiture of certain non-strategic assets and inventory write-downs. Other costs generally include costs related to employee relocation, asset relocation, vacant facility costs (i.e., taxes and insurance) and other charges. Restructuring charges include charges related to approved, but not yet announced, facility closures.
The following is a summary of restructuring charges, net of adjustments, for our restructuring activities:

| Three Months Ended March 31, 2025
(Amounts in thousands) | Severance |  | Contract Termination |  | Asset Write-Downs (Gains) |  | Other |  | Total
COS | $ | 7,655 |  |  | $ | — |  |  | $ | 2,000 |  |  | $ | 1,070 |  |  | $ | 10,725 |
SG&A | 22 |  |  | — |  |  | — |  |  | 84 |  |  | 106 |
Total | $ | 7,677 |  |  | $ | — |  |  | $ | 2,000 |  |  | $ | 1,154 |  |  | $ | 10,831 |

| Three Months Ended March 31, 2024
(Amounts in thousands) | Severance |  | Contract Termination |  | Asset Write-Downs (Gains) |  | Other |  | Total
COS | $ | 3,985 |  |  | $ | — |  |  | $ | — |  |  | $ | 444 |  |  | $ | 4,429 |
SG&A | 701 |  |  | — |  |  | — |  |  | — |  |  | 701 |
Total | $ | 4,686 |  |  | $ | — |  |  | $ | — |  |  | $ | 444 |  |  | $ | 5,130 |

The following is a summary of total inception to date restructuring charges, net of adjustments, related to our 2025 Realignment Programs:
24

| Inception to Date
(Amounts in thousands) | Severance |  | Contract Termination |  | Asset Write-Downs (Gains) |  | Other |  | Total
COS | $ | 7,655 |  |  | $ | — |  |  | $ | 2,000 |  |  | $ | 1,070 |  |  | $ | 10,725 |
SG&A | 22 |  |  | — |  |  | — |  |  | 84 |  |  | 106 |
Total | $ | 7,677 |  |  | $ | — |  |  | $ | 2,000 |  |  | $ | 1,154 |  |  | $ | 10,831 |

The following is a summary of total inception to date restructuring charges, net of adjustments, related to our 2023 Realignment Programs:

| Inception to Date
(Amounts in thousands) | Severance |  | Contract Termination |  | Asset Write-Downs |  | Other |  | Total
COS | $ | 14,164 |  |  | $ | 301 |  |  | $ | 13,655 |  |  | $ | 4,063 |  |  | $ | 32,183 |
SG&A | 1,106 |  |  | — |  |  | 12,621 |  |  | (24) |  |  | 13,703 |
Loss on sale of business(1) | — |  |  | — |  |  | — |  |  | 12,981 |  |  | 12,981 |
Total | $ | 15,270 |  |  | $ | 301 |  |  | $ | 26,276 |  |  | $ | 17,020 |  |  | $ | 58,867 |

(1) Loss on sale of business related to NAF AB control valves business as described within Note 1, "Significant Accounting Policies and Accounting Developments," to our consolidated financial statements included in our 2024 Annual Report.
The following represents the activity, primarily severance charges from reductions in force, related to the restructuring reserves for the three months ended March 31, 2025 and 2024:

(Amounts in thousands) | 2025 |  | 2024
Balance at January 1, | $ | 8,300 |  |  | $ | 8,184 |
Charges, net of adjustments | 8,831 |  |  | 5,130 |
Cash expenditures | (3,537) |  |  | (387) |
Other non-cash adjustments, including currency | (684) |  |  | (849) |
Balance at March 31, | $ | 12,910 |  |  | $ | 12,078 |

Item 2.MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our condensed consolidated financial statements and notes thereto, and the other financial data included elsewhere in this Quarterly Report. The following discussion should also be read in conjunction with our audited consolidated financial statements, and notes thereto, and "Management’s Discussion and Analysis of Financial Condition and Results of Operations" ("MD&A") included in our 2024 Annual Report.
EXECUTIVE OVERVIEW
Our Company
We are a world-leading manufacturer and aftermarket service provider of comprehensive flow control systems. We develop and manufacture precision-engineered flow control equipment integral to the movement, control and protection of the flow of materials in our customers’ critical processes. Our product portfolio of pumps, valves, seals, automation and aftermarket services support global industries, including energy, chemical, power generation and general, which includes water management and pharmaceuticals, where our products and services enable customers to achieve their goals. Through our manufacturing platform and global network of Quick Response Centers ("QRCs"), we offer a broad array of aftermarket equipment services, such as installation, advanced diagnostics and turnkey maintenance programs. We currently have approximately 16,000 employees globally and a footprint of manufacturing facilities and QRCs i n approximatel y 50 countries.
25

Our business model is significantly influenced by the capital and operating spending of global infrastructure industries for the placement of new products into service and maintenance spending for aftermarket services for existing operations. The worldwide installed base of our products is an important source of aftermarket revenue, where products are relied upon to maximize the operating time of many key industrial processes. We continue to invest in our aftermarket strategy to provide local support to drive customer investments in our offerings and use of our services to replace or repair installed products. The aftermarket portion of our business also helps provide business stability during various economic periods. The aftermarket business, which is primarily served by our network of 155 QRCs (some of which are shared by our two business segments) located around the globe, provides a variety of service offerings for our customers including spare parts, service solutions, product life cycle solutions and other value-added services. It is generally a higher margin business compared to our original equipment business and a key component of our profitable growth strategy.
Our operations are conducted through two business segments that are referenced throughout this MD&A:
•FPD designs, manufactures, pretests, distributes and services highly custom engineered pumps, pre-configured industrial pumps, pump systems, mechanical seals, auxiliary systems and replacement parts and related services; and
•FCD designs, manufactures and distributes a broad portfolio of engineered-to-order and configured-to-order isolation valves, control valves, valve automation products and related equipment.
Our business segments share a focus on industrial flow control technology and have a high number of common customers. These segments also have complementary product offerings and technologies that are often combined in applications that provide us a net competitive advantage. Our segments also benefit from our global footprint, our economies of scale in reducing administrative and overhead costs to serve customers more cost effectively and our shared leadership for operational support functions, such as research and development marketing and supply chain.
The reputation of our product portfolio is built on more than 50 well-respected brand names such as Worthington, IDP, SIHI, INNOMAG, Valtek, Limitorque, Durco and Argus, which we believe to be one of the most comprehensive in the industry. Our products and services are sold either directly or through designated channels to more than 10,000 companies, including some of the world’s leading engineering, procurement and construction ("EPC") firms, original equipment manufacturers, distributors and end users.
Through the Flowserve Business System, we are committed to operational excellence, which includes continuous enhancements of our global supply chain capability to increase our ability to meet global customer demands and improve the quality and timely delivery of our products over the long term. Additionally, we continue to devote resources to improving the supply chain processes across our business segments to find areas of synergy and cost reduction and to improving our supply chain management capabilities to meet global customer demands. We also remain focused on improving on-time delivery and quality, while managing warranty costs across our global operations, through our operational excellence program. The goal of the program, which includes lean manufacturing, six sigma business management strategy and value engineering, is to maximize service fulfillment to customers through on-time delivery, reduced cycle time and quality at the highest internal productivity. Another main focus area of the Flowserve Business System is portfolio excellence. As part of these efforts, in 2024, we launched the complexity reduction ("CORE") program that focuses on product rationalization and continuous improvement of our overall product portfolio.
In the first quarter of 2023, we identified and initiated certain realignment activities concurrent with the consolidation of our FPD aftermarket and pump operations into a single operating model. This consolidated operating model was designed to better align our go-to-market strategy with our product offerings, enable end-to-end lifecycle responsibility and accountability, and to facilitate more efficient operations. Collectively, the above realignment activities are referred to as the "2023 Realignment Programs." The activities of the 2023 Realignment Programs were identified and implemented in phases throughout 2023 and 2024 and are substantially completed. In the fourth quarter of 2024, we launched the CORE program within the portfolio excellence category of the Flowserve Business System. During 2025 we also initiated certain other portfolio and footprint optimization activities. These optimization activities, together with the CORE program are referred to as the "2025 Realignment Programs."
2025 Outlook
We continue to see growth from the end-markets we serve and focus on our strategic plan that takes a balanced approach to integrating both short-term and long-term initiatives and aims to accelerate growth through three key areas: diversification, decarbonization, and digitization, the "3D Strategy." Our strategy is expected to deliver sustainable growth, while the Flowserve Business System is expected to unlock gains in organizational and operational efficiency. The current macroeconomic environment is dynamic and uncertainty exists given the trade policy actions introduced through April, including higher import tariffs in a number of countries in which we operate, the potential implementation of modified or new tariffs and related retaliatory actions. We plan to leverage our global footprint, expansive manufacturing network, flexible
26

supply chain and ability to incorporate tariff impacts into pricing decisions to minimize the economic impact of this uncertainty to our business. We will continue to monitor and manage macroeconomic trends and uncertainties, including inflationary and recessionary pressures resulting from the ongoing tariffs and geopolitical climate; however, with our strong backlog, improved execution and recent acquisition of MOGAS, we expect to deliver annual revenue growth in 2025.
As of March 31, 2025, we have cash and cash equi valents of $540.8 million and $662.2 million of borr owings available under our Second Amended and Restated Credit Agreement. We do not currently anticipate, nor are we aware of, any significant market conditions or commitments that would change any of our conclusions of the liquidity currently available to us. We will continue to actively monitor the credit markets in order to maintain sufficient liquidity and access to capital throughout 2025.
OUR RESULTS OF OPERATIONS — Three months ended March 31, 2025 and 2024
Throughout this discussion of our results of operations, we discuss the impact of fluctuations in foreign currency exchange rates. We have calculated currency effects on operations by translating current year results on a monthly basis at prior year exchange rates for the same periods.
As discussed in Note 2, "Acquisition," to our condensed consolidated financial statements included in this Quarterly Report, effective October 15, 2024, we acquired for inclusion in FCD, all of the equity interests of MOGAS Industries, Inc., MOGAS Real Estate LLC and MOGAS Systems & Consulting LLC (such entities collectively, "MOGAS"). We incurred $1.3 million in acquisition and integration related costs for the three-month period ended March 31, 2025 associated with the acquisition which are included within selling, general and administrative expense ("SG&A") in our condensed consolidated statement of income. The impact of the acquisition of MOGAS is not material for the three-month period ended March 31, 2025.
Our realignment activities are implemented in phases. We currently anticipate a total investment of approximately $23 million in the 2025 Realignment Programs that have been evaluated and initiated, of which $8 million is estimated to be non-cash. We are evaluating the annualized cost savings expected to be achieved upon completion of the activities of the 2025 Realignment Programs that have been identified and initiated to date. Actual savings could vary from expected savings. There are certain remaining realignment activities that are currently being evaluated, but have not yet been approved and therefore are not included in the above anticipated total investment or estimated savings.
Realignment Activity
The following tables present our realignment activity by segment.

| Three Months Ended March 31, 2025
(Amounts in thousands) | FPD |  | FCD |  | Subtotal–Reportable Segments |  | Eliminations and All Other |  | Consolidated Total
Total Realignment Charges |  |  |  |  |  |  |  |  |
COS | $ | 2,979 |  |  | $ | 7,101 |  |  | $ | 10,080 |  |  | $ | (66) |  |  | $ | 10,014 |
SG&A(1) | (997) |  |  | (121) |  |  | (1,118) |  |  | (185) |  |  | (1,303) |
Total | $ | 1,982 |  |  | $ | 6,980 |  |  | $ | 8,962 |  |  | $ | (251) |  |  | $ | 8,711 |

(1) Includes the immaterial reversal of previously recognized realignment charges associated with our 2023 Realignment Programs, which was recognized in the first quarter of 2025. Our 2023 Realignment Programs are substantially completed.

| Three Months Ended March 31, 2024
(Amounts in thousands) | FPD |  | FCD |  | Subtotal–Reportable Segments |  | Eliminations and All Other |  | Consolidated Total
Total Realignment Charges |  |  |  |  |  |  |  |  |
COS | $ | 5,044 |  |  | $ | 767 |  |  | $ | 5,811 |  |  | $ | (138) |  |  | $ | 5,673 |
SG&A | 1,041 |  |  | $ | 114 |  |  | 1,155 |  |  | 339 |  |  | 1,494 |
Total | $ | 6,085 |  |  | $ | 881 |  |  | $ | 6,966 |  |  | $ | 201 |  |  | $ | 7,167 |

27

Consolidated Results
Bookings, Sales and Backlog

| Three Months Ended March 31,
(Amounts in millions) | 2025 |  | 2024
Bookings | $ | 1,226.4 |  |  | $ | 1,038.3 |
Sales | 1,144.5 |  |  | 1,087.5 |

We revised the end market categories for bookings during the first quarter of 2025 to better reflect the end markets of our customers and better align with Flowserve's strategic focus. All bookings by industry amounts discussed below, including the 2024 comparative period, have been reclassified from five categories (i.e., oil and gas, chemical, power, water management and general industries) to four categories (i.e., energy, chemical, power and general industries) to conform to our current classification of end markets. The revisions implemented are as follows:
•the oil and gas end market is now referred to as the energy end market;
•the chemical end market no longer includes pharmaceuticals; and
•the general industries end market now includes pharmaceuticals and water management.
We define a booking as the receipt of a customer order that contractually engages us to perform activities on behalf of our customer with regard to manufacturing, service or support. Bookings recorded and subsequently canceled within the year-to-date period are excluded from year-to-date bookings. Bookings for the three months ended March 31, 2025 increased by $188.1 million, or 18.1%, as compared to the same period in 2024. The increase included negative currency effects of $25 million. The increased bookings were driven by increased customer orders of $88 million in the general industries, $58 million in the power generation industry and $41 million in the energy industry, partially offset by a decrease of $4 million in the chemical industry. The increase in customer bookings was driven by both original equipment and aftermarket bookings.
Sales for the three months ended March 31, 2025 increase d by $57.0 million, or 5.2%, a s compared to the same period in 2024. The increase included negative currency effects of approximately $24 million. The increased sales were driven by both aftermarket and original equipment customer sales, with increased customer sales of $27 million into North America, $21 million into the Middle East, $20 million into Asia Pacific and $7 million into Latin America, partially offset by decreased customer sales of $9 million into both Europe and Africa, respectively. Net sales t o international customers, including export sales from the United States, were approxim ately 63% a nd 64% of total sales for the three months ended March 31, 2025 and 2024, respectively. Aftermarket sales represented approximately 51% of total sales for both periods.
B acklog represents the aggregate value of booked but uncompleted customer orders and is influenced primarily by bookings, sales, cancellat ions and currency effects. Backlog of $2,902.9 million at March 31, 2025 increased by $113.3 million, or 4.1%, as compared to December 31, 2024. Currency effects provided an increase of approximately $49 million (currency effects on backlog are calculated using the change in period end exchange rates). A pproximately 40% of the backlog at March 31, 2025 and 37% of the backlog at December 31, 2024 was related to aftermarket orders. Backlog includes our unsatisfied (or partially unsatisfied) performance obligations of approximately $962 million related to contracts having an original expected duration of over one year as discussed in Note 3, "Revenue Recognition," to our condensed consolidated financial statements included in this Quarterly Report.
Gross Profit and Gross Profit Margin

| Three Months Ended March 31,
(Amounts in millions, except percentages) | 2025 |  | 2024
Gross profit | $ | 369.3 |  |  | $ | 339.0 |
Gross profit margin | 32.3 | % |  | 31.2 | %

Gross profit for the three months ended March 31, 2025 increased by $30.3 million, or 8.9%, as compared to the same period in 2024. Gross profit margin for the three months ended March 31, 2025 of 32.3% increased from 31.2% for the same period in 2024. The increase in gross profit margin was primarily due to the favorable impact of previously implemented sales price increases and an improved selective bidding approach, partially offset by higher broad-based annual incentive compensation, increased charges of $4.3 million related to our realignment activities and $3.5 million in amortization of step-up
28

in value of acquired inventories and acquisition related intangibles assets associated with the MOGAS acquisition as compared to the same period in 2024.
Selling, General and Administrative Expense

| Three Months Ended March 31,
(Amounts in millions, except percentages) | 2025 |  | 2024
SG&A | $ | 243.2 |  |  | $ | 228.4 |
SG&A as a percentage of sales | 21.2 | % |  | 21.0 | %

SG&A for the three months ended March 31, 2025 increased by $14.8 million, or 6.5%, as compared to the same period in 2024. Currency effects yielded a decrease of approximately $5 million. SG&A increased due to higher broad-based annual incentive compensation, increased bad debt expense of $2.2 million, a reversal of previously recognized expenses of $2.0 million related to our financial exposure in Russia in the first quarter of 2024 that did not recur, $1.3 million of acquisition and integration expense related to the MOGAS acquisition and $1.3 million in amortization of step-up in value of acquisition related intangible assets associated with the MOGAS acquisition, partially offset by a decrease in research and development costs of $3.1 million and decreased charges of $2.8 million related to our realignment activities as compared to the same period in 2024. SG&A as a percentage of sales for the three months ended March 31, 2025 increased 20 basis points driven by cost increases.
Net Earnings from Affiliates

| Three Months Ended March 31,
(Amounts in millions) | 2025 |  | 2024
Net earnings from affiliates | $ | 5.7 |  |  | $ | 2.5 |

Net earnings from affiliates for the three months ended March 31, 2025 increased by $3.2 million, or 128.0%, as compared to the same period in 2024. The increase in net earnings was primarily a result of increased earnings of our FPD joint ventures in South Korea.
Operating Income and Operating Margin

| Three Months Ended March 31,
(Amounts in millions, except percentages) | 2025 |  | 2024
Operating income | $ | 131.9 |  |  | $ | 113.1 |
Operating income as a percentage of sales | 11.5 | % |  | 10.4 | %

Operating income for the three months ended March 31, 2025 increased by $18.8 million, or 16.6%, as compared to the same period in 2024. The increase included negative currency effects of approximately $4 million. The increase was primarily a result of the $30.3 million increase in gross profit, partially offset by $14.8 million increase in SG&A.
29

Interest Expense and Interest Income

| Three Months Ended March 31,
(Amounts in millions) | 2025 |  | 2024
Interest expense | $ | (19.2) |  |  | $ | (15.3) |
Interest income | 1.7 |  |  | 1.2 |

Interest expense for the three months ended March 31, 2025 increased $3.9 million, as compared to the same period in 2024, primarily due to higher outstanding debt during the period. Interest income for the three months ended March 31, 2025 increased by $0.5 million primarily due to higher average balance as compared to the same period in 2024.
Other Income (Expense), Net

| Three Months Ended March 31,
(Amounts in millions) | 2025 |  | 2024
Other income (expense), net | $ | (17.3) |  |  | $ | (0.9) |

Other expense, net for the three months ended March 31, 2025 increased $16.4 million as compared to the same period in 2024, primarily due to a $9.8 million increase in losses arising from transactions on foreign exchange forward contracts and a $2.9 million increase in losses from transactions in currencies other than our sites' functional currencies. The net change was primarily due to the foreign currency exchange rate movements in the Euro, Swedish krona, Singapore dollar and Brazilian real during the three months ended March 31, 2025, as compared to the same period in 2024. The three-month period ended March 31, 2025 also includes a pension settlement loss of $1.5 million incurred in conjunction with the freeze of our U.S. Qualified pension plan, which represents a portion of the estimated full year expected settlement loss of $6 million - $7 million triggered due to expected cash outflows exceeding service and interest costs.
Income Taxes and Tax Rate

| Three Months Ended March 31,
(Amounts in millions, except percentages) | 2025 |  | 2024
Provision for (benefit from) income taxes | $ | 17.7 |  |  | $ | 20.1 |
Effective tax rate | 18.3 | % |  | 20.5 | %

The effective tax rate of 18.3% for the three months ended March 31, 2025 decreased from 20.5% for the same period in 2024. The effective tax rate varied from the U.S. federal statutory rate for the three months ended March 31, 2025 primarily due to the net impact of U.S. discrete items, partially offset by state income taxes. Refer to Note 15, "Income Taxes," to our condensed consolidated financial statements included in this Quarterly Report for further discussion.
Other Comprehensive Income (Loss)

| Three Months Ended March 31,
(Amounts in millions) | 2025 |  | 2024
Other comprehensive income (loss) | $ | 47.9 |  |  | $ | (26.9) |

Other comprehensive income for the three months ended March 31, 2025 increased by $74.8 million from a loss of $26.9 million in the same period in 2024. T he income w as due to foreign currency translation adjustments resu lting primarily from
30

exchange rate movements of the Euro, British pound and Brazilian real versus the U.S. dollar during t he three months ended March 31, 2025, as compared to the same period in 2024.
Business Segments
We conduct our operations through two business segments based on the type of product and how we manage the business. We evaluate segment performance and allocate resources based on each segment’s operating income. The key operating results for our two business segments, FPD and FCD, are discussed below.
Flowserve Pumps Division Segment Results
Our largest business segment is FPD, through which we design, manufacture, pretest, distribute and service highly custom engineered pumps, pre-configured industrial pumps, pump systems, mechanical seals and auxiliary systems (collectively referred to as "original equipment") and related services. FPD includes highly engineered pump products with longer lead times and mechanical seals that are generally manufactured within shorter lead times. FPD also manufactures replacement parts and related equipment and provides aftermarket services. FPD primarily operates in the energy, power generation, chemical, and general industries. FPD operates in 49 countries with 37 manufacturing facilities worldwide, 12 of which are located in North America, 11 in Europe and the Middle East, eight in Asia Pacific and six in Latin America, and it operates 130 QRCs, including those co-located in manufacturing facilities and/or shared with FCD.

| Three Months Ended March 31,
(Amounts in millions, except percentages) | 2025 |  | 2024
Bookings | $ | 852.9 |  |  | $ | 703.5 |
Sales | 783.1 |  |  | 769.4 |
Gross profit | 268.5 |  |  | 247.9 |
Gross profit margin | 34.3 | % |  | 32.2 | %
SG&A | 137.7 |  |  | 139.7 |
Segment operating income | 136.5 |  |  | 110.9 |
Segment operating income as a percentage of sales | 17.4 | % |  | 14.4 | %

As discussed above, we revised the end market categories for bookings during the first quarter of 2025. All bookings by industry amounts discussed below, including the 2024 comparative period, have been reclassified from five categories (i.e., oil and gas, chemical, power, water management, and general industries) to four categories (i.e., energy, chemical, power and general industries) to conform to our current classification of end markets.
Bookings for the three months ended March 31, 2025 increased by $149.4 million, or 21.2%, as compared to the same period in 2024. The increase included negative currency effects of approximately $20 million. The increase in customer bookings was primarily driven by increased customer orders of $80.0 million in the general industries, $54.8 million in the power generation industry and $17.0 million in the energy industry, partially offset by decreased customer orders of $1.3 million in the chemical industry. Customer bookings increased $79.1 million into North America, $37.2 million into the Middle East, $28.3 million into Africa and $24.5 million into Europe and were partially offset by decreased customer orders of $9.6 million into Asia Pacific and $9.3 million into Latin America. The increase in customer bookings was driven by both original equipment and aftermarket bookings.
Sales for the three months ended March 31, 2025 increased by $13.7 million, or 1.8% as compared to the same period in 2024 and included negative currency effects of approximately $19 million. The increase was driven by aftermarket customer sales. Increased customer sales of approximately $16.3 million into North America, $9.6 million into the Middle East and $1.2 million into Latin America were partially offset by decreased customer sales of $9.3 million into Asia Pacific, $4.2 million into Europe and $2.4 million into Africa.
Gross profit for the three months ended March 31, 2025 increased by $20.6 million, or 8.3%, as compared to the same period in 2024. Gross profit margin for the three months ended March 31, 2025 of 34.3% increased from 32.2% for the same period in 2024. The increase in gross profit margin was primarily due to strategic sourcing decisions, an improved selective bidding approach, favorable mix and decreased charges of $2.1 million related to our realignment activities, partially offset by higher broad-based annual incentive compensation as compared to the same period in 2024.
SG&A for the three months ended March 31, 2025 decreased by $2.0 million, or 1.4%, as compared to the same period in 2024. Currency effects yielded a decrease of approximately $4 million. The decrease in SG&A was primarily due to decreased research and development costs of $2.8 million, decreased charges of $2.0 million related to our realignment activities and
31

decreased bad debt expense of $0.4 million, partially offset by higher broad-based annual incentive compensation and a reversal of previously recognized expenses of $2.0 million related to our financial exposure in Russia in the first quarter of 2024 that did not recur as compared to the same period in 2024.
Operating income for the three months ended March 31, 2025 increased by $25.6 million, or 23.1%, as compared to the same period in 2024. The increase included negative currency effects of approximately $3 million. The increase w as primarily due to the $20.6 million increase in gross profit and the $2.0 million decrease in SG&A.
Backlog of $2,018.7 million at March 31, 2025 increased by $88.3 million, or 4.6%, as compared to December 31, 2024. Currency effects provided an increase of approximately $40 million.
Flow Control Division Segment Results
FCD designs, manufactures and distributes a broad portfolio of engineered-to-order and configured-to-order isolation valves, control valves, valve automation products and related equipment. FCD leverages its experience and application know-how by offering a complete menu of engineered services to complement its expansive product portfolio. FCD has a total of 44 manufacturing facilities and QRCs in 22 countries around the world, with seven of its 19 manufacturing operations located in Europe and the Middle East, six located in the United States, five located in Asia Pacific and one located in Latin America. Based on independent industry sources, we believe that FCD ranks among the top three largest industrial valve suppliers worldwide.

| Three Months Ended March 31,
(Amounts in millions, except percentages) | 2025 |  | 2024
Bookings | $ | 376.0 |  |  | $ | 341.1 |
Sales | 364.1 |  |  | 320.5 |
Gross profit | 100.2 |  |  | 92.7 |
Gross profit margin | 27.5 | % |  | 28.9 | %
SG&A | 68.7 |  |  | 58.0 |
Segment operating income | 31.5 |  |  | 34.7 |
Segment operating income as a percentage of sales | 8.6 | % |  | 10.8 | %

As discussed above, we revised the end market categories for bookings during the first quarter of 2025. All bookings by industry amounts discussed below, including the 2024 comparative period, have been reclassified from five categories (i.e., oil and gas, chemical, power, water management, and general industries) to four categories (i.e., energy, chemical, power and general industries) to conform to our current classification of end markets.
Bookings for the three months ended March 31, 2025 increased by $34.9 million, or 10.2%, as compared to the same period in 2024. Bookings included negative currency effects of approximately $5 million. The increase in customer bookings was primarily driven by increased customer orders of $23.8 million in the energy industry, $7.7 million in the general industries and $3.2 million in the power generation industry, partially offset by decreased customer orders of $2.4 million in the chemical industry. Increased customer bookings were driven by increased orders of approximately $41.8 million into North America, $26.1 million into the Middle East and $1.7 million into Latin America, partially offset by decreased orders of $20.0 million into Europe, $15.9 million into Asia Pacific and $1.4 million into Africa. The increase in customer bookings was driven by both customer original equipment and aftermarket bookings.
Sales for the three months ended March 31, 2025 increased $43.6 million, or 13.6%, as compared to the same period in 2024. The increase included negative currency effects of approximately $5 million. The increase was driven by both aftermarket and original equipment customer sales. Increased customer sales of $29.7 million into Asia Pacific, $11.5 million into the Middle East, $10.9 million into North America and $5.7 million into Latin America were partially offset by decreased sales of $6.7 million into Africa and $4.7 million into Europe.
Gross profit for the three months ended March 31, 2025 increased by $7.5 million, or 8.1%, as compared to the same period in 2024. Gross profit margin for the three months ended March 31, 2025 of 27.5% decreased from 28.9% for the same period in 2024. The decrease in gross profit margin was primarily due to increased charges of $6.3 million related to our realignment activities and $3.5 million in amortization of step-up in value of acquired inventories and acquisition related intangibles assets associated with the MOGAS acquisition, partially offset by the favorable impact of previously implemented sales price increases as compared to the same period in 2024.
32

SG&A for the three months ended March 31, 2025 increased by $10.7 million, or 18.4%, as compared to the same period in 2024. Currency effects yielded a decrease of approximately $1 million. Th e increase in SG&A was primarily due to increased bad debt expense of $2.6 million, $1.3 million of acquisition and integration expense related to the MOGAS acquisition, $1.3 million in amortization of step-up in value of acquisition related intangible assets associated with the MOGAS acquisition and a $0.3 million increase in research and development costs, partially offset by decreased charges of $0.2 million related to our realignment activities as compared to the same period in 2024.
Operating income for the three months ended March 31, 2025 decreased by $3.2 million, or 9.2%, as compared to the same period in 2024. The decrease included negative currency effects of approximately $1 million. The decrease was primarily due to the $10.7 million increase in SG&A partially offset by $7.5 million increase in gross profit.
Backlog of $889.4 million at March 31, 2025 increased by $19.8 million, or 2.3%, as compared to December 31, 2024. Currency effects provided an increase of approximately $9 million.
LIQUIDITY AND CAPITAL RESOURCES
Cash Flow Analysis

| Three Months Ended March 31,
(Amounts in millions) | 2025 |  | 2024
Net cash flows provided (used) by operating activities | $ | (49.9) |  |  | $ | 62.3 |
Net cash flows provided (used) by investing activities | (11.3) |  |  | (13.6) |
Net cash flows provided (used) by financing activities | (84.2) |  |  | (54.2) |

Existing cash, cash generated by operations and borrowings available under our Second Amended and Restated Credit Agreement are our primary sources of short-term liquidity. We monitor the depository institutions that hold our cash and cash equivalents on a regular basis, and we believe that we have placed our deposits with creditworthy financial institutions. Our sources of operating cash generally include the sale of our products and services and the conversion of our working capital, particularly accounts receivable and inventories.
Our cash balance decreased by $134.6 million to $540.8 million at March 31, 2025, as compared to December 31, 2024. The cash activity during the first three months of 2025 included cash used by operating activities, $27.6 million in dividend payments, $21.1 million of share repurchases, $15.0 million contingent consideration payment related to the MOGAS acquisition, $11.7 million in capital expenditures and $9.4 million of payments on our $500.0 million unsecured term loan facility (the "Term Loan").
For the three months ended March 31, 2025, our cash used by operating activities was $49.9 million, as compared to cash provided of $62.3 million for the same period in 2024. Cash flow used for working capital increased for the three months ended March 31, 2025, primarily due to increased cash flows used by, or decreased cash flows provided by, accounts receivable, contract assets, accounts payable and accrued liabilities, partially offset by increased cash flows provided by, or decreased cash flows used by, inventories, prepaid expenses and other assets, and contract liabilities as compared to the same period in 2024.
Increases in accounts receivable used $50.7 million of cash flow for the three months ended March 31, 2025, compared to cash used of $39.7 million for the same period in 2024. As of March 31, 2025, our days’ sales outstanding ("DSO") was 82 days as compared to 76 days as of March 31, 2024.
Increases in contract assets used $9.4 million of cash flow for the three months ended March 31, 2025, as compared to cash used of $8.1 million for the same period in 2024.
Changes in inventory provided $8.8 million of cash flow for the three months ended March 31, 2025, as compared to cash used of $11.5 million for the same period in 2024. Inventory turns were 3.6 times at March 31, 2025, as compared to 3.3 times as of March 31, 2024.
Decreases in accounts payable used $16.9 million of cash flow for the three months ended March 31, 2025, as compared to cash provided of $5.1 million for the same period in 2024. Decreases in accrued liabi lities used $89.5 million of cash flow for th e three months ended March 31, 2025, as co mpared to cash provided of $30.9 million for the same period in 2024, which was partially driven by the earlier payout of our annual performance-based incentive compensation which occurred in the first quarter of 2025 as compared to the second quarter of 2024.
Changes in contract liabilities used $3.6 million of cash flow for the three months ended March 31, 2025, as compared to cash used of $6.4 million for the same period in 2024.
33

Cash flows used by investing activities during the three months ended March 31, 2025 were $11.3 million, as compared to cash used of $13.6 million for the same period in 2024. Capital expenditures during the three months ended March 31, 2025 were $11.7 million, a decrease of $1.9 million as compared to the same period in 2024. Our capital expenditures are generally focused on strategic initiatives to pursue information technology infrastructure, ongoing scheduled replacements and upgrades and cost reduction opportunities. In 2025, we currently estimate capital expenditures to be between $80 million and $90 million, before consideration of any acquisition activity.
Cash flows used by financing activities during the three months ended March 31, 2025 were $84.2 million, as compared to $54.2 million of cash flow used for the same period in 2024. Cash outflows in the three months ended March 31, 2025 resulted primarily from the $27.6 million of dividend payments, $21.1 million in stock repurchases, $15.0 million contingent consideration payment related to the MOGAS acquisition, $11.1 million in payments related to tax withholding for stock-based compensation and $9.4 million of payments on our Term Loan. Cash outflows during the three months ended March 31, 2024 resulted primarily from the $27.7 million of dividend payments and $15.0 million of payments on our Term Loan.
As of March 31, 2025, we had an available capacity of $662.2 million on our Second Amended and Restated Credit Agreemen t, which provides for a $800.0 mill ion unsecured revolving credit facility with a maturity date of October 10, 2029. Our borrowing capacity is subject to financial covenant limitations based on the terms of our Second Amended and Restated Credit Agreement and is also reduced by outstanding letters of credit. Our Second Amended and Restated Credit Agreement is committed and held by a diversified group of financial institutions. Refer to Note 7, "Debt and Finance Lease Obligations," to our condensed consolidated financial statements included in this Quarterly Report for additional information concerning our Second Amended and Restated Credit Agreement.
During the three months ended March 31, 2025, we have made no cash contributions to our U.S. pension plan. We have no obligation to make contributions to our U.S. pension plans in 2025, but have authorization for contributions up to $10 million. At December 31, 2024, our U.S. pension plan was fully funded as defined by applicable law. We continue to maintain an asset allocation consistent with our strategy to maximize total return, while reducing portfolio risks through asset class diversification.
Considering our current debt structure and cash needs, we currently believe cash flows generated from operating activities combined with availability under our Second Amended and Restated Credit Agreement and our existing cash balance will be sufficient to meet our cash needs for our short-term (next 12 months) and long-term (beyond the next 12 months) business needs. However, cash flows from operations could be adversely affected by a decrease in the rate of general global economic growth and an extended decrease in capital spending of our customers, as well as economic, political and other risks associated with sales of our products, operational factors, competition, regulatory actions, fluctuations in foreign currency exchange rates and fluctuations in interest rates, among other factors. See "Financing" and "Cautionary Note Regarding Forward-Looking Statements" below.
As of March 31, 2025, we have $258.8 million of remaining capacity for Board of Directors approved share repurchases. While we currently intend to continue to return cash through dividends and/or share repurchases for the foreseeable future, any future returns of cash through dividends will be reviewed individually, declared by our Board of Directors at its discretion and implemented by management.
Financing
Credit Facilities
See Note 7, "Debt and Finance Lease Obligations," to our condensed consolidated financial statements included in this Quarterly Report for a discussion of our Second Amended and Restated Credit Agreement and related covenants. We were in compliance with all applicable covenants under our Second Amended and Restated Credit Agreement as of March 31, 2025.
As of March 31, 2025, we have cash and cash equi valents of $540.8 million and $662.2 million of borrowings available under our Second Amended and Restated Credit Agreement. We do not currently anticipate, nor are we aware of, any significant market conditions or commitments that would change any of our conclusions of the liquidity currently available to us. We expect the liquidity discussed above coupled with the costs savings measures planned and already in place will further enable us to maintain adequate liquidity over the short-term (next 12 months) and long-term (beyond the next 12 months). We will continue to actively monitor the credit markets in order to maintain sufficient liquidity and access to capital throughout 2025.
34

OUR CRITICAL ACCOUNTING ESTIMATES
Management’s discussion and analysis of financial condition and results of operations are based on our condensed consolidated financial statements and related footnotes contained within this Quarterly Report. Our critical accounting policies used in the preparation of our condensed consolidated financial statements were discussed in "Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations" of our 2024 Annual Report. The critical policies, for which no significant changes have occurred in the three months ended March 31, 2025, include:
•Revenue Recognition;
•Deferred Taxes, Tax Valuation Allowances and Tax Reserves;
•Reserves for Contingent Loss;
•Pension and Postretirement Benefits; and
•Valuation of Goodwill, Indefinite-Lived Intangible Assets and Other Long-Lived Assets.
The process of preparing condensed consolidated financial statements in conformity with U.S. GAAP requires the use of estimates and assumptions to determine certain of the assets, liabilities, revenues and expenses. These estimates and assumptions are based upon what we believe is the best information available at the time of the estimates or assumptions. The estimates and assumptions could change materially as conditions within and beyond our control change. Accordingly, actual results could differ materially from those estimates. The significant estimates are reviewed quarterly with the Audit Committee of our Board of Directors.
Based on an assessment of our accounting policies and the underlying judgments and uncertainties affecting the application of those policies, we believe that our condensed consolidated financial statements provide a meaningful and fair perspective of our consolidated financial condition and results of operations. This is not to suggest that other general risk factors, such as changes in worldwide demand, changes in material costs, performance of acquired businesses and others, could not adversely impact our consolidated financial condition, results of operations and cash flows in future periods. See "Cautionary Note Regarding Forward-Looking Statements" below.
ACCOUNTING DEVELOPMENTS
We have presented the information about pronouncements not yet implemented in Note 1, "Basis of Presentation and Accounting Policies," to our condensed consolidated financial statements included in this Quarterly Report.
Cautionary Note Regarding Forward-Looking Statements
This Quarterly Report includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. Words or phrases such as, "may," "should," "expects," "could," "intends," "plans," "anticipates," "estimates," "believes," "predicts" or other similar expressions are intended to identify forward-looking statements, which include, without limitation, statements concerning our future financial performance, future debt and financing levels, investment objectives, implications of litigation and regulatory investigations and other management plans for future operations and performance.
The forward-looking statements included in this Quarterly Report are based on our current expectations, projections, estimates and assumptions. These statements are only predictions, not guarantees. Such forward-looking statements are subject to numerous risks and uncertainties that are difficult to predict. These risks and uncertainties may cause actual results to differ materially from what is forecast in such forward-looking statements. Specific factors that might cause such a difference include, without limitation, the following:
•global supply chain disruptions and the current inflationary environment could adversely affect the efficiency of our manufacturing and increase the cost of providing our products to customers;
•a portion of our bookings may not lead to completed sales, and our ability to convert bookings into revenues at acceptable profit margins;
•changes in the global economic conditions and the potential for unexpected cancellations or delays of customer orders in our reported backlog;
•our dependence on our customers' ability to make required capital investment and maintenance expenditures;
•if we are not able to successfully execute and realize the expected financial benefits from our restructuring, realignment and other cost-saving initiatives, our business could be adversely affected;
•the substantial dependence of our sales on the success of the energy, chemical, power generation and general
industries;
•the adverse impact of volatile raw materials prices on our products and operating margins;
•economic, political and other risks associated with our international operations, including military actions, trade embargoes, epidemics or pandemics and changes to tariffs or trade agreements that could affect customer markets, particularly North African, Latin American, Asian and Middle Eastern markets and global oil and gas producers, and non-compliance with U.S. export/re-export control, foreign corrupt practice laws, economic sanctions and import laws and regulations;
•the impact of public health emergencies, such as outbreaks of epidemics, pandemics, and contagious diseases, on our business and operations;
•increased aging and slower collection of receivables, particularly in Latin America and other emerging markets;
•potential adverse effects resulting from the implementation of new tariffs and related retaliatory actions and changes to or uncertainties related to tariffs and trade agreements;
•our exposure to fluctuations in foreign currency exchange rates, including in hyperinflationary countries such as Argentina;
•potential adverse consequences resulting from litigation to which we are a party, such as litigation involving asbestos-containing material claims;
•expectations regarding acquisitions and the integration of acquired businesses;
•the potential adverse impact of an impairment in the carrying value of goodwill or other intangible assets;
•our dependence upon third-party suppliers whose failure to perform timely could adversely affect our business operations;
•the highly competitive nature of the markets in which we operate;
•if we are not able to maintain our competitive position by successfully developing and introducing new products and integrate new technologies, including artificial intelligence and machine learning;
•environmental compliance costs and liabilities;
•potential work stoppages and other labor matters;
•access to public and private sources of debt financing;
•our inability to protect our intellectual property in the United States, as well as in foreign countries;
•obligations under our defined benefit pension plans;
•our internal control over financial reporting may not prevent or detect misstatements because of its inherent limitations, including the possibility of human error, the circumvention or overriding of controls, or fraud;
•the recording of increased deferred tax asset valuation allowances in the future or the impact of tax law changes on such deferred tax assets could affect our operating results;
•our information technology infrastructure could be subject to service interruptions, data corruption, cyber-based attacks or network security breaches, which could disrupt our business operations and result in the loss of critical and confidential information; and
•ineffective internal controls could impact the accuracy and timely reporting of our business and financial results.
These and other risks and uncertainties are more fully discussed in the risk factors identified in "Item 1A. Risk Factors" in Part I of our 2024 Annual Report and Part II of this Quarterly Report, and may be identified in our Quarterly Reports on Form 10-Q and our other filings with the SEC and/or press releases from time to time. All forward-looking statements included in this document are based on information available to us on the date hereof, and we assume no obligation to update any forward-looking statement.
Item 3.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
We have market risk exposure arising from changes in foreign currency exchange rate movements in foreign exchange forward contracts. We are exposed to credit-related losses in the event of non-performance by counterparties to financial instruments, but we currently expect our counterparties will continue to meet their obligations given their current creditworthiness.
Foreign Currency Exchange Rate Risk
A substantial portion of our operations are conducted by our subsidiaries outside of the United States in currencies other than the U.S. dollar. Almost all of our non-U.S. subsidiaries conduct their business primarily in their local currencies, which are also their functional currencies. Foreign currency exposures arise from translation of foreign-denominated assets and liabilities into U.S. dollars and from transactions, including firm commitments and anticipated transactions, denominated in a currency other than our or a non-U.S. subsidiary’s functional currency. We recognized net gains (losses) associated with foreign currency translation of $47.6 million and $(28.2) million for the three months ended March 31, 2025 and 2024, respectively, wh ich are included in other comprehensive income (loss).
We employ a foreign currency risk management strategy to minimize potential changes in cash flows from unfavorable foreign currency exchange rate movements. Where available, the use of foreign exchange forward contracts allows us to mitigate transactional exposure to exchange rate fluctuations as the gains or losses incurred on the foreign exchange forward contracts will help offset, in whole or in part, losses or gains on the underlying foreign currency exposure. Our policy allows foreign currency coverage only for identifiable foreign currency exposures. As of March 31, 2025, we had a U.S. dollar equivalent of $665.4 million in aggregate notional amount outstanding in foreign exchange contracts with third parties, compared with $695.9 million at December 31, 2024. Transactional currency gains and losses arising from transactions outside of our sites’ functional currencies and changes in fair value of foreign exchange contracts are included in our consolidated results of operations. We recognized foreign currency net gains (losses) of $(11.4) million and $1.3 million for the three months ended March 31, 2025 and 2024, respectively, which are included in other income (expens e), net in the accompanying condensed consolidated statements of income.
Based on a sensitivity analysis at March 31, 2025, a 10% change in the foreign currency exchange rates for the three months ended March 31, 2025 would have impacted our net earnings by approximately $10 million. This calculation assumes that all currencies change in the same direction and proportion relative to the U.S. dollar and that there are no indirect effects, such as changes in non-U.S. dollar sales volumes or prices.
Item 4.CONTROLS AND PROCEDURES
Disclosure Controls and Procedures
Disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) are controls and other procedures that are designed to ensure that the information that we are required to disclose in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Principal Executive Officer and Principal Financial Officer, as appropriate to allow timely decisions regarding required disclosure.
In connection with the preparation of this Quarterly Report, our management, under the supervision and with the participation of our Principal Executive Officer and Principal Financial Officer, carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of March 31, 2025. Based on this evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective as of March 31, 2025.
Changes in Internal Control Over Financial Reporting
There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the quarter ended March 31, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
35

PART II — OTHER INFORMATION
Item 1.LEGAL PROCEEDINGS
We are party to the legal proceedings that are described in Note 12, "Legal Matters and Contingencies," to our condensed consolidated financial statements included in "Item 1. Financial Statements" of this Quarterly Report, and such disclosure is incorporated by reference into this "Item 1. Legal Proceedings." In addition to the foregoing, we and our subsidiaries are named defendants in certain other routine lawsuits incidental to our business and are involved from time to time as parties to governmental proceedings, all arising in the ordinary course of business. Although the outcome of lawsuits or other proceedings involving us and our subsidiaries cannot be predicted with certainty, and the amount of any liability that could arise with respect to such lawsuits or other proceedings cannot be predicted accurately, management does not currently expect the amount of any liability that could arise with respect to these matters, either individually or in the aggregate, to have a material adverse effect on our financial position, results of operations or cash flows.
Item 1A.RISK FACTORS
There are numerous factors that affect our business, financial condition, results of operations, cash flows, reputation and/or prospects, many of which are beyond our control. In addition to other information set forth in this Quarterly Report, careful consideration should be given to "Item 1A. Risk Factors" in Part I and "Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations" in Part II of our 2024 Annual Report, which contain descriptions of significant factors that might cause the actual results of operations in future periods to differ materially from those currently projected in the forward-looking statements contained therein.
There have been no material changes in risk factors discussed in our 2024 Annual Report and subsequent SEC filings. The risks described in this Quarterly Report filed for the period ended March 31, 2025, our 2024 Annual Report and in our other SEC filings or press releases from time to time are not the only risks we face. Additional risks and uncertainties are currently deemed immaterial based on management's assessment of currently available information, which remains subject to change; however, new risks that are currently unknown to us may surface in the future that materially adversely affect our business, financial condition, results of operations or cash flows.
Item 2.UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Note 14, "Shareholders' Equity," to our condensed consolidated financial statements included in this Quarterly Report includes a discussion of our share repurchase program and payment of quarterly dividends on our common stock.
Effective February 19, 2024, the Board of Directors approved a $300.0 million share repurchase authorization, which included approximately $96.1 million of remaining capacity under the prior $500.0 million share repurchase authorization. During the quarter ended March 31, 2025, we repurchased a total of 427,574 shares of our common stock as part of our share repurchase program for $21.1 million, representing an average cost of $49.32 per share. As of March 31, 2025, we have $258.8 million of remaining capacity under our current share repurchase program. The following table sets forth the activity for each of the three months during the quarter ended March 31, 2025:

| Total Number of Shares Purchased |  | Average Price Paid per Share |  | Total Number of Shares Purchased as Part of Publicly Announced Program (1) |  | Maximum Number of Shares (or Approximate Dollar Value) That May Yet Be Purchased Under the Program (in millions) |
Period |  |  |  |
January 1 - 31 | 500 |  | (2) | $ | 58.59 |  |  | — |  |  | $ | 279.9 |  |
February 1 - 28 | 145,510 |  | (3) | 62.07 |  |  | — |  |  | 279.9 |  |
March 1 - 31 | 43,851 |  | (2) | 55.04 |  |  | 427,574 |  |  | 258.8 |  |
Total | 189,861 |  |  | $ | 60.43 |  |  | 427,574 |  |  |  |

__________________________________
(1)On November 13, 2014, our Board of Directors approved a $500.0 million share repurchase authorization. Effective February 19, 2024, the Board of Directors approved a $300.0 million share repurchase authorization, which included approximately $96.1 million of remaining capacity under the prior $500.0 million share repurchase authorization. Our share repurchase program does not have an expiration date, and we reserve the right to limit or terminate the repurchase program at any time without notice.
(2)Represents shares that were tendered by employees to satisfy minimum tax withholding amounts for Restricted Shares.
(3)Includes 143,989 shares that were tendered by employees to satisfy minimum tax withholding amounts for Restricted Shares at an average price per share of $62.14 and 1,521 shares purchased at a price of $54.99 per share by a rabbi trust that we established in connection with our director deferral plans, pursuant to which non-employee di rectors may elect to defer directors’ quarterly cash compensation to be paid at a later date in the form of common stock.
36

Item 3.DEFAULTS UPON SENIOR SECURITIES
None
Item 4.MINE SAFETY DISCLOSURES
Not applicable.
Item 5.OTHER INFORMATION
Insider Trading Arrangements.
Our directors and executive officers may, from time to time, enter into plans or other arrangements for the purchase or sale of our shares that are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or may represent a non-Rule 10b5-1 trading arrangement under the Exchange Act. During the quarter ended March 31, 2025, no such plans or other arrangements were adopted, terminated or modified.
37

Item 6.EXHIBITS

Exhibit No. |  | Description
3.1 |  | Restated Certificate of Incorporation of Flowserve Corporation, as amended and restated effective May 20, 2021 (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K (File No. 001-13179)) filed on May 25, 2021).
3.2 |  | Flowserve Corporation By-Laws, as amended and restated effective February 7, 2025 (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K (File No. 001-13179) filed on February 11, 2025).
10.1+ |  | Form of 2025 Performance Restricted Stock Unit Agreement for certain officers pursuant to the Flowserve Corporation 2020 Long-Term Incentive Plan.*
10.2+ |  | Form of 2025 Restricted Stock Unit Agreement for certain officers pursuant to the Flowserve Corporation 2020 Long-Term Incentive Plan.*
31.1+ |  | Certification of Principal Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2+ |  | Certification of Principal Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1++ |  | Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2++ |  | Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS |  | XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH |  | XBRL Taxonomy Extension Schema Document
101.CAL |  | XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB |  | XBRL Taxonomy Extension Label Linkbase Document
101.PRE |  | XBRL Taxonomy Extension Presentation Linkbase Document
101.DEF |  | XBRL Taxonomy Extension Definition Linkbase Document
104 |  | The cover page from the Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2025, formatted in Inline XBRL (included as Exhibit 101)

_______________________
*Management contracts and compensatory plans and arrangements required to be filed as exhibits to this Quarterly Report on Form 10-Q.
+ Filed herewith.
++ Furnished herewith.
38

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

|  | FLOWSERVE CORPORATION |

Date: | April 29, 2025 | /s/ Amy B. Schwetz |
|  | Amy B. Schwetz |
|  | Senior Vice President and Chief Financial Officer (Principal Financial Officer) |

Date: | April 29, 2025 | /s/ Scott K. Vopni |
|  | Scott K. Vopni |
|  | Vice President and Chief Accounting Officer (Principal Accounting Officer) |

39